{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:19:08Z","timestamp":1791472748359,"version":"4.3.4"},"reference-count":355,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2017,7,28]],"date-time":"2017-07-28T00:00:00Z","timestamp":1501200000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Saf"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1007\/s40264-017-0578-2","type":"journal-article","created":{"date-parts":[[2017,7,28]],"date-time":"2017-07-28T14:31:33Z","timestamp":1501252293000},"page":"1171-1198","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":95,"title":["Neurological Adverse Effects Attributable to \u03b2-Lactam Antibiotics: A Literature Review"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8887-3233","authenticated-orcid":false,"given":"Samuel","family":"Deshayes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Coquerel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renaud","family":"Verdon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,7,28]]},"reference":[{"key":"578_CR1","unstructured":"ESAC-Net surveillance data. Summary of the latest data on antibiotic consumption in the European Union. 2015. http:\/\/ecdc.europa.eu\/en\/eaad\/antibiotics-news\/Documents\/antimicrobial-consumption-ESAC-Net-summary-2015.pdf . Accessed 8 May 2016."},{"key":"578_CR2","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1517\/14740338.2012.643866","volume":"11","author":"P Lagac\u00e9-Wiens","year":"2012","unstructured":"Lagac\u00e9-Wiens P, Rubinstein E. Adverse reactions to \u03b2-lactam antimicrobials. Expert Opin Drug Saf. 2012;11:381\u201399.","journal-title":"Expert Opin Drug Saf"},{"key":"578_CR3","unstructured":"European Centre for Disease Prevention and Control. Surveillance of antimicrobial consumption in Europe 2012. 2014. http:\/\/ecdc.europa.eu\/en\/publications\/Publications\/antimicrobial-consumption-europe-esac-net-2012.pdf . Accessed 8 May 2016."},{"key":"578_CR4","unstructured":"Institut de veille sanitaire (InVS), Agence nationale de s\u00e9curit\u00e9 du m\u00e9dicament et des produits de sant\u00e9 (ANSM). Consommation d\u2019antibiotiques et r\u00e9sistance aux antibiotiques en France: n\u00e9cessit\u00e9 d\u2019une mobilisation d\u00e9termin\u00e9e et durable. Bilan des donn\u00e9es de surveillance. 2014. http:\/\/invs.santepubliquefrance.fr\/Publications-et-outils\/Rapports-et-syntheses\/Maladies-infectieuses\/2014\/Consommation-d-antibiotiques-et-resistance-aux-antibiotiques-en-France-necessite-d-une-mobilisation-determinee-et-durable . Accessed 8 May 2016."},{"key":"578_CR5","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1212\/WNL.0000000000002455","volume":"86","author":"S Bhattacharyya","year":"2016","unstructured":"Bhattacharyya S, Darby RR, Raibagkar P, Gonzalez Castro LN, Berkowitz AL. Antibiotic-associated encephalopathy. Neurology. 2016;86:963\u201371.","journal-title":"Neurology"},{"key":"578_CR6","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s10072-012-1001-5","volume":"34","author":"UK Misra","year":"2013","unstructured":"Misra UK, Kalita J, Chandra S, Nair PP. Association of antibiotics with status epilepticus. Neurol Sci. 2013;34:327\u201331.","journal-title":"Neurol Sci"},{"key":"578_CR7","unstructured":"Drug-induced convulsions. Report from Boston Collaborative Drug Surveillance Program. Lancet. 1972;2:677\u20139."},{"key":"578_CR8","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1212\/WNL.34.12.1582","volume":"34","author":"RO Messing","year":"1984","unstructured":"Messing RO, Closson RG, Simon RP. Drug-induced seizures: a 10-year experience. Neurology. 1984;34:1582\u20136.","journal-title":"Neurology"},{"key":"578_CR9","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0140-6736(77)92011-6","volume":"309","author":"J Porter","year":"1977","unstructured":"Porter J, Jick H. Drug-induced anaphylaxis, convulsions, deafness, and extrapyramidal symptoms. Lancet. 1977;309:587\u20138.","journal-title":"Lancet"},{"issue":"1489\u20131511","key":"578_CR10","first-page":"e4","volume":"36","author":"A Mattappalil","year":"2014","unstructured":"Mattappalil A, Mergenhagen KA. Neurotoxicity with antimicrobials in the elderly: a review. Clin Ther. 2014;36(1489\u20131511):e4.","journal-title":"Clin Ther"},{"key":"578_CR11","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1128\/CMR.00007-10","volume":"23","author":"R Nau","year":"2010","unstructured":"Nau R, Sorgel F, Eiffert H. Penetration of drugs through the blood\u2013cerebrospinal fluid\/blood\u2013brain barrier for treatment of central nervous system infections. Clin Microbiol Rev. 2010;23:858\u201383.","journal-title":"Clin Microbiol Rev"},{"key":"578_CR12","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s10096-005-0021-y","volume":"24","author":"KM Chow","year":"2005","unstructured":"Chow KM, Hui AC, Szeto CC. Neurotoxicity induced by beta-lactam antibiotics: from bench to bedside. Eur J Clin Microbiol Infect Dis. 2005;24:649\u201353.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"578_CR13","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0749-0704(05)70367-5","volume":"13","author":"KL Wallace","year":"1997","unstructured":"Wallace KL. Antibiotic-induced convulsions. Crit Care Clin. 1997;13:741\u201362.","journal-title":"Crit Care Clin"},{"key":"578_CR14","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1365-2125.2011.03991.x","volume":"72","author":"MF Grill","year":"2011","unstructured":"Grill MF, Maganti RK. Neurotoxic effects associated with antibiotic use: management considerations: neurotoxicity of antibiotics. Br J Clin Pharmacol. 2011;72:381\u201393.","journal-title":"Br J Clin Pharmacol"},{"key":"578_CR15","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0002-9343(01)00767-7","volume":"111","author":"JE Mart\u00ednez-Rodr\u00edguez","year":"2001","unstructured":"Mart\u00ednez-Rodr\u00edguez JE, Barriga FJ, Santamaria J, Iranzo A, Pareja JA, Revilla M, et al. Nonconvulsive status epilepticus associated with cephalosporins in patients with renal failure. Am J Med. 2001;111:115\u20139.","journal-title":"Am J Med"},{"key":"578_CR16","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ejphar.2004.06.004","volume":"496","author":"CEL Lindquist","year":"2004","unstructured":"Lindquist CEL, Dalziel JE, Cromer BA, Birnir B. Penicillin blocks human alpha 1 beta 1 and alpha 1 beta 1 gamma 2S GABAA channels that open spontaneously. Eur J Pharmacol. 2004;496:23\u201332.","journal-title":"Eur J Pharmacol"},{"key":"578_CR17","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1345\/aph.1L307","volume":"42","author":"MF Grill","year":"2008","unstructured":"Grill MF, Maganti R. Cephalosporin-induced neurotoxicity: clinical manifestations, potential pathogenic mechanisms, and the role of electroencephalographic monitoring. Ann Pharmacother. 2008;42:1843\u201350.","journal-title":"Ann Pharmacother"},{"key":"578_CR18","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1592\/phco.31.4.408","volume":"31","author":"AD Miller","year":"2011","unstructured":"Miller AD, Ball AM, Bookstaver PB, Dornblaser EK, Bennett CL. Epileptogenic potential of carbapenem agents: mechanism of action, seizure rates, and clinical considerations. Pharmacotherapy. 2011;31:408\u201323.","journal-title":"Pharmacotherapy"},{"key":"578_CR19","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1046\/j.1528-1157.2001.34701.x","volume":"42","author":"BS Koppel","year":"2001","unstructured":"Koppel BS, Hauser WA, Politis C, van Duin D, Daras M. Seizures in the critically ill: the role of imipenem. Epilepsia. 2001;42:1590\u20133.","journal-title":"Epilepsia"},{"key":"578_CR20","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1080\/08880010050122852","volume":"17","author":"C Karadeniz","year":"2000","unstructured":"Karadeniz C, O\u011fuz A, Canter B, Serdaro\u011flu A. Incidence of seizures in pediatric cancer patients treated with imipenem\/cilastatin. Pediatr Hematol Oncol. 2000;17:585\u201390.","journal-title":"Pediatr Hematol Oncol"},{"key":"578_CR21","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/jac\/45.1.5","volume":"45","author":"SR Norrby","year":"2000","unstructured":"Norrby SR. Neurotoxicity of carbapenem antibiotics: consequences for their use in bacterial meningitis. J Antimicrob Chemother. 2000;45:5\u20137.","journal-title":"J Antimicrob Chemother"},{"key":"578_CR22","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ijantimicag.2003.11.004","volume":"23","author":"KM Chow","year":"2004","unstructured":"Chow KM, Szeto CC, Hui AC-F, Li PK-T. Mechanisms of antibiotic neurotoxicity in renal failure. Int J Antimicrob Agents. 2004;23:213\u20137.","journal-title":"Int J Antimicrob Agents"},{"key":"578_CR23","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/jac\/6.2.161","volume":"6","author":"PJ Nicholls","year":"1980","unstructured":"Nicholls PJ. Neurotoxicity of penicillin. J Antimicrob Chemother. 1980;6:161\u20135.","journal-title":"J Antimicrob Chemother"},{"key":"578_CR24","first-page":"89","volume":"25","author":"R-H Ye","year":"2011","unstructured":"Ye R-H, Lin M-Y, Sung C-C, Lin S-H. Standard dose of piperacillin induced neurotoxicity in advanced renal failure. Acta Nephrol. 2011;25:89\u201392.","journal-title":"Acta Nephrol"},{"key":"578_CR25","doi-asserted-by":"crossref","first-page":"474","DOI":"10.5414\/CN107247","volume":"80","author":"M-J Wen","year":"2013","unstructured":"Wen M-J, Sung C-C, Chau T, Lin S-H. Acute prolonged neurotoxicity associated with recommended doses of ertapenem in 2 patients with advanced renal failure. Clin Nephrol. 2013;80:474\u20138.","journal-title":"Clin Nephrol"},{"key":"578_CR26","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/jac\/27.4.405","volume":"27","author":"SE Schliamser","year":"1991","unstructured":"Schliamser SE, Cars O, Norrby SR. Neurotoxicity of \u03b2-lactam antibiotics: predisposing factors and pathogenesis. J Antimicrob Chemother. 1991;27:405\u201325.","journal-title":"J Antimicrob Chemother"},{"key":"578_CR27","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1212\/WNL.0000000000002023","volume":"85","author":"R Sutter","year":"2015","unstructured":"Sutter R, Ruegg S, Tschudin-Sutter S. Seizures as adverse events of antibiotic drugs: a systematic review. Neurology. 2015;85:1332\u201341.","journal-title":"Neurology."},{"key":"578_CR28","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0303-8467(88)90013-3","volume":"90","author":"T Uchihara","year":"1988","unstructured":"Uchihara T, Tsukagoshi H. Myoclonic activity associated with cefmetazole, with a review of neurotoxicity of cephalosporins. Clin Neurol Neurosurg. 1988;90:369\u201371.","journal-title":"Clin Neurol Neurosurg."},{"key":"578_CR29","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1749-6632.1967.tb50228.x","volume":"145","author":"PI Lerner","year":"1967","unstructured":"Lerner PI, Smith H, Weinstein L. Penicillin neurotoxicity. Ann N Y Acad Sci. 1967;145:310\u20138.","journal-title":"Ann N Y Acad Sci."},{"key":"578_CR30","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/archinte.1967.00300010049008","volume":"120","author":"H Smith","year":"1967","unstructured":"Smith H, Lerner PI, Weinstein L. Neurotoxicity and \u201cmassive\u201d intravenous therapy with penicillin. A study of possible predisposing factors. Arch Intern Med. 1967;120:47\u201353.","journal-title":"Arch Intern Med."},{"key":"578_CR31","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","volume":"30","author":"CA Naranjo","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239\u201345.","journal-title":"Clin Pharmacol Ther."},{"key":"578_CR32","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1001\/jama.1945.92860040001007","volume":"127","author":"HC Johnson","year":"1945","unstructured":"Johnson HC, Walker AE. Intraventricular penicillin: a note of warning. J Am Med Assoc. 1945;127:217\u20139.","journal-title":"J Am Med Assoc."},{"key":"578_CR33","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1136\/pgmj.44.518.891","volume":"44","author":"N Conway","year":"1968","unstructured":"Conway N, Beck E, Somerville J. Penicillin encephalopathy. Postgrad Med J. 1968;44:891\u20137.","journal-title":"Postgrad Med J."},{"key":"578_CR34","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1001\/archneur.1971.00490030058006","volume":"25","author":"ME Raichle","year":"1971","unstructured":"Raichle ME, Kutt H, Louis S, McDowell F. Neurotoxicity of intravenously administered penicillin G. Arch Neurol. 1971;25:232\u20139.","journal-title":"Arch Neurol."},{"key":"578_CR35","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1001\/jama.1967.03120150077011","volume":"200","author":"HA Bloomer","year":"1967","unstructured":"Bloomer HA, Barton LJ, Maddock RK. Penicillin-induced encephalopathy in uremic patients. JAMA. 1967;200:121\u20133.","journal-title":"JAMA."},{"key":"578_CR36","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1212\/WNL.16.7.693","volume":"16","author":"MB Oldstone","year":"1966","unstructured":"Oldstone MB, Nelson E. Central nervous system manifestations of penicillin toxicity in man. Neurology. 1966;16:693\u2013700.","journal-title":"Neurology."},{"key":"578_CR37","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJM196804182781601","volume":"278","author":"KB Seamans","year":"1968","unstructured":"Seamans KB, Gloor P, Dobell RA, Wyant JD. Penicillin-induced seizures during cardiopulmonary bypass. A clinical and electroencephalographic study. N Engl J Med. 1968;278:861\u20138.","journal-title":"N Engl J Med."},{"key":"578_CR38","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1001\/archsurg.1970.01340210001001","volume":"100","author":"S Lavy","year":"1970","unstructured":"Lavy S, Stein H. Convulsions in septicemic patients treated by penicillin: the value of electroencephalograph examination. Arch Surg. 1970;100:225\u20138.","journal-title":"Arch Surg."},{"key":"578_CR39","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1001\/archsurg.1968.01340040158033","volume":"97","author":"JB Borman","year":"1968","unstructured":"Borman JB, Eyal Z. Neurotoxic effects of large doses of penicillin administered intravenously. Arch Surg. 1968;97:662\u20135.","journal-title":"Arch Surg."},{"key":"578_CR40","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1136\/bmj.280.6226.1254-a","volume":"280","author":"CJ Wickerts","year":"1980","unstructured":"Wickerts CJ, Asaba H, Gunnarsson B, Bygdeman S, Bergstrom J. Combined carbon haemoperfusion and haemodialysis in treatment of penicillin intoxication. Br Med J. 1980;280:1254\u20135.","journal-title":"Br Med J."},{"key":"578_CR41","first-page":"1781","volume":"11","author":"P Trunet","year":"1982","unstructured":"Trunet P, Bouvier AM, Otterbein G, Lepresle E, Lhoste F, Rapin M. Penicillin-induced encephalopathy. Nouv Presse Med. 1982;11:1781\u20134.","journal-title":"Nouv Presse Med"},{"key":"578_CR42","first-page":"1445","volume":"1","author":"D Brahams","year":"1987","unstructured":"Brahams D. Penicillin overdose and deafness. Lancet. 1987;1:1445.","journal-title":"Lancet."},{"key":"578_CR43","first-page":"217","volume":"27","author":"S Lavy","year":"1969","unstructured":"Lavy S, Stein H. Penicillin convulsions. Electroencephalogr. Clin Neurophysiol. 1969;27:217\u20138.","journal-title":"Clin Neurophysiol."},{"key":"578_CR44","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0140-6736(63)91133-4","volume":"1","author":"SV Humphries","year":"1963","unstructured":"Humphries SV. Convulsant effect of penicillin on the cerebral cortex. Lancet. 1963;1:115\u20136.","journal-title":"Lancet."},{"key":"578_CR45","first-page":"1002","volume":"279","author":"MI Marks","year":"1968","unstructured":"Marks MI, Hirshfeld S. Neurotoxicity of penicillin. N Engl J Med. 1968;279:1002\u20133.","journal-title":"N Engl J Med."},{"key":"578_CR46","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/00005072-195207000-00010","volume":"11","author":"MM Cohen","year":"1952","unstructured":"Cohen MM. Fatality following the use of intrathecal penicillin; case report. J Neuropathol Exp Neurol. 1952;11:335\u20139.","journal-title":"J Neuropathol Exp Neurol."},{"key":"578_CR47","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1001\/jama.1947.02880180018004","volume":"134","author":"JR Reuling","year":"1947","unstructured":"Reuling JR, Cramer C. Intrathecal penicillin. J Am Med Assoc. 1947;134:16\u20138.","journal-title":"J Am Med Assoc."},{"key":"578_CR48","first-page":"631","volume":"27","author":"C Arseni","year":"1969","unstructured":"Arseni C, Tudor I. Penicillin epilepsy in man. Electroencephalogr Clin Neurophysiol. 1969;27:631.","journal-title":"Electroencephalogr Clin Neurophysiol."},{"key":"578_CR49","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1365-2044.1975.tb00796.x","volume":"30","author":"A Bordbar","year":"1975","unstructured":"Bordbar A, Beheshti M. Post-operative convulsions due to penicillin applied to the spinal theca. Anaesthesia. 1975;30:56\u20138.","journal-title":"Anaesthesia."},{"key":"578_CR50","doi-asserted-by":"crossref","unstructured":"A sixty-three year old woman with fulminant meningitis and convulsions. Am J Med. 1967;42:264\u201372.","DOI":"10.1016\/0002-9343(67)90024-1"},{"key":"578_CR51","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1177\/106002809202600106","volume":"26","author":"RW Barrons","year":"1992","unstructured":"Barrons RW, Murray KM, Richey RM. Populations at risk for penicillin-induced seizures. Ann Pharmacother. 1992;26:26\u20139.","journal-title":"Ann Pharmacother."},{"key":"578_CR52","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1001\/archneur.1979.00500490071013","volume":"36","author":"JC Sackellares","year":"1979","unstructured":"Sackellares JC, Smith DB. Myoclonus with electrocerebral silence in a patient receiving penicillin. Arch Neurol. 1979;36:857.","journal-title":"Arch Neurol."},{"key":"578_CR53","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/j.1552-4604.1974.tb01364.x","volume":"14","author":"B Fossieck","year":"1974","unstructured":"Fossieck B, Parker RH. Neurotoxicity during intravenous infusion of penicillin. A review. J Clin Pharmacol. 1974;14:504\u201312.","journal-title":"J Clin Pharmacol."},{"key":"578_CR54","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1001\/jama.1970.03180070084016","volume":"214","author":"NA Kurtzman","year":"1970","unstructured":"Kurtzman NA, Rogers PW, Harter HR. Neurotoxic reaction to penicillin and carbenicillin. JAMA. 1970;214:1320\u20131.","journal-title":"JAMA."},{"key":"578_CR55","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1136\/jnnp.57.6.705","volume":"57","author":"Y River","year":"1994","unstructured":"River Y, Averbuch-Heller L, Weinberger M, Meiner Z, Mevorach D, Schlesinger I, et al. Antibiotic induced meningitis. J Neurol Neurosurg Psychiatry. 1994;57:705\u20138.","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"578_CR56","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1258\/002221504772784612","volume":"118","author":"PA Escada","year":"2004","unstructured":"Escada PA, Capucho C, Madeira da Silva JF. Sudden sensorineural hearing loss following intramuscular administration of penicillin. J Laryngol Otol. 2004;118:143\u20135.","journal-title":"J Laryngol Otol."},{"key":"578_CR57","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1001\/archneurpsyc.1947.02300300049005","volume":"58","author":"A Walker","year":"1947","unstructured":"Walker A. Toxic effects of intrathecal administration of penicillin. Arch Neurol Psychiatry. 1947;58:39.","journal-title":"Arch Neurol Psychiatry."},{"key":"578_CR58","doi-asserted-by":"crossref","first-page":"910","DOI":"10.7326\/0003-4819-52-4-910","volume":"52","author":"L Farmer","year":"1960","unstructured":"Farmer L, Echlin FA, Loughlin WC, Breakey AS, Duvoisin R. Pachymeningitis apparently due to penicillin hypersensitivity. Ann Intern Med. 1960;52:910\u20134.","journal-title":"Ann Intern Med."},{"key":"578_CR59","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1542\/peds.43.1.50","volume":"43","author":"BD Schmitt","year":"1969","unstructured":"Schmitt BD, Krivit W. Benign intracranial hypertension associated with a delayed penicillin reaction. Pediatrics. 1969;43:50\u20133.","journal-title":"Pediatrics."},{"key":"578_CR60","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1176\/jnp.11.4.517-a","volume":"11","author":"R Rao","year":"1999","unstructured":"Rao R. Penicillin psychosis in later life: Hoigne\u2019s syndrome revisited. J Neuropsychiatry Clin Neurosci. 1999;11:517\u20138.","journal-title":"J Neuropsychiatry Clin Neurosci."},{"key":"578_CR61","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/j.1460-9592.2004.01525.x","volume":"15","author":"HJ Przybylo","year":"2005","unstructured":"Przybylo HJ, Przybylo JH, Todd Davis A, Cote CJ. Acute psychosis after anesthesia: the case for antibiomania. Pediatr Anesth. 2005;15:703\u20135.","journal-title":"Pediatr Anesth."},{"key":"578_CR62","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/j.1749-6632.1969.tb46405.x","volume":"166","author":"P Gloor","year":"1969","unstructured":"Gloor P. Epileptogenic action of penicillin. Ann N Y Acad Sci. 1969;166:350\u201360.","journal-title":"Ann N Y Acad Sci."},{"key":"578_CR63","doi-asserted-by":"crossref","first-page":"703","DOI":"10.3171\/jns.1990.72.5.0703","volume":"72","author":"JD Michenfelder","year":"1990","unstructured":"Michenfelder JD, Cucchiara RF, Sundt TM Jr. Influence of intraoperative antibiotic choice on the incidence of early postcraniotomy seizures. J Neurosurg. 1990;72:703\u20135.","journal-title":"J Neurosurg."},{"key":"578_CR64","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/00005072-195104000-00004","volume":"10","author":"IM Tarlov","year":"1951","unstructured":"Tarlov IM, Perlmutter I, Berman AJ. Paralysis caused by penicillin injection; mechanism of complication a warning. J Neuropathol Exp Neurol. 1951;10:158\u201376.","journal-title":"J Neuropathol Exp Neurol."},{"key":"578_CR65","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1001\/jama.1946.02870410011004","volume":"132","author":"LC Kolb","year":"1946","unstructured":"Kolb LC, Gray SJ. Peripheral neuritis as a complication of penicillin therapy. J Am Med Assoc. 1946;132:323\u20136.","journal-title":"J Am Med Assoc."},{"key":"578_CR66","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1001\/jama.1946.02870450015004","volume":"132","author":"TC Erickson","year":"1946","unstructured":"Erickson TC, Masten MG, Suckle HM. Complications of intrathecal use of penicillin. J Am Med Assoc. 1946;132:561\u20135.","journal-title":"J Am Med Assoc."},{"key":"578_CR67","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1469-8749.1993.tb11633.x","volume":"35","author":"S Keskin","year":"1993","unstructured":"Keskin S, Konkol RJ. Seizure exacerbation related to beta-lactam antibiotics in a child with cerebral dysgenesis. Dev Med Child Neurol. 1993;35:267\u201374.","journal-title":"Dev Med Child Neurol."},{"key":"578_CR68","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0140-6736(51)91439-0","volume":"258","author":"RCL Batchelor","year":"1951","unstructured":"Batchelor RCL, Horne GO, Rogerson HL. An unusual reaction to procaine penicillin in aqueous suspension. Lancet. 1951;258:195\u20138.","journal-title":"Lancet."},{"key":"578_CR69","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0301-0503(79)80058-2","volume":"7","author":"L Kryst","year":"1979","unstructured":"Kryst L, Wanyura H. Hoign\u00e9\u2019s syndrome\u2014its course and symptomatology. J Maxillofac Surg. 1979;7:320\u20136.","journal-title":"J Maxillofac Surg."},{"key":"578_CR70","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/00007435-197801000-00002","volume":"5","author":"TF Downham","year":"1978","unstructured":"Downham TF, Cawley RA, Salley SO, Dal Santo G. Systemic toxic reactions to procaine penicillin G. Sex Transm Dis. 1978;5:4\u20139.","journal-title":"Sex Transm Dis."},{"key":"578_CR71","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/j.1365-4362.1995.tb01089.x","volume":"34","author":"EM Einterz","year":"1995","unstructured":"Einterz EM, Einterz RM. Immediate nonallergic psychotic reaction to intramuscular procaine penicillin. Int J Dermatol. 1995;34:627\u20139.","journal-title":"Int J Dermatol."},{"key":"578_CR72","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1192\/bjp.156.4.554","volume":"156","author":"ST Ilechukwu","year":"1990","unstructured":"Ilechukwu ST. Acute psychotic reactions and stress response syndromes following intramuscular aqueous procaine penicillin. Br J Psychiatry. 1990;156:554\u20139.","journal-title":"Br J Psychiatry."},{"key":"578_CR73","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0306-9877(94)90128-7","volume":"42","author":"A Araskiewicz","year":"1994","unstructured":"Araskiewicz A, Rybakowski JK. Hoigne\u2019s syndrome: a procaine-induced limbic kindling. Med Hypotheses. 1994;42:261\u20134.","journal-title":"Med Hypotheses."},{"key":"578_CR74","first-page":"129","volume":"35","author":"A Bj\u00f6rnberg","year":"1960","unstructured":"Bj\u00f6rnberg A, Selstam J. Acute psychotic reaction after injection of procaine penicillin. A report of 33 cases. Acta Psychiatr Scand. 1960;35:129\u201339.","journal-title":"Acta Psychiatr Scand."},{"key":"578_CR75","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2190\/KNQT-UEU4-GAQ2-57L6","volume":"16","author":"JL Cummings","year":"1986","unstructured":"Cummings JL, Barritt CF, Horan M. Delusions induced by procaine penicillin: case report and review of the syndrome. Int J Psychiatry Med. 1986;16:163\u20138.","journal-title":"Int J Psychiatry Med."},{"key":"578_CR76","doi-asserted-by":"crossref","first-page":"358","DOI":"10.7326\/0003-4819-81-3-358","volume":"81","author":"JE Galpin","year":"1974","unstructured":"Galpin JE, Chow AW, Yoshikawa TT, Guze LB. \u201cPseudoanaphylactic\u201d reactions from inadvertent infusion of procaine penicillin G. Ann Intern Med. 1974;81:358\u20139.","journal-title":"Ann Intern Med."},{"key":"578_CR77","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/00006205-198411000-00007","volume":"9","author":"BJ Landis","year":"1984","unstructured":"Landis BJ, Dunn L. Adverse toxic reaction to aqueous procaine penicillin G. Nurse Pract. 1984;9:36 (41\u20132, 44).","journal-title":"Nurse Pract."},{"key":"578_CR78","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0140-6736(74)93303-0","volume":"2","author":"HE Menke","year":"1974","unstructured":"Menke HE, Pepplinkhuizen L. Letter: Acute non-allergic reaction to aqueous procaine penicillin. Lancet. 1974;2:723\u20134.","journal-title":"Lancet."},{"key":"578_CR79","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1176\/ajp.124.7.999","volume":"124","author":"S Jacobson","year":"1968","unstructured":"Jacobson S. Psychotic reaction to penicillin. Am J Psychiatry. 1968;124:999.","journal-title":"Am J Psychiatry."},{"key":"578_CR80","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0196-0644(83)80650-7","volume":"12","author":"DL Lankin","year":"1983","unstructured":"Lankin DL, Jewell GM, Grinvalsky HT, Fye DL. Psychotic-like reaction to procaine penicillin G. Ann Emerg Med. 1983;12:507\u20139.","journal-title":"Ann Emerg Med."},{"key":"578_CR81","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1001\/archinte.1967.00300040049008","volume":"120","author":"R Tompsett","year":"1967","unstructured":"Tompsett R. Pseudoanaphylactic reactions to procaine penicillin G. Arch Intern Med. 1967;120:565\u20137.","journal-title":"Arch Intern Med."},{"key":"578_CR82","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1001\/jama.1953.63690150004009c","volume":"152","author":"AR Sohval","year":"1953","unstructured":"Sohval AR. Severe immediate constitutional reaction to penicillin. J Am Med Assoc. 1953;152:1430\u20131.","journal-title":"J Am Med Assoc."},{"key":"578_CR83","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1001\/archderm.1973.01620260071034","volume":"108","author":"H Malota","year":"1973","unstructured":"Malota H, Dusek J, Jezdinsky J. Letter: Nonallergic reaction after aqueous procaine penicillin G. Arch Dermatol. 1973;108:727.","journal-title":"Arch Dermatol."},{"issue":"139","key":"578_CR84","first-page":"1073","volume":"1985","author":"S Press","year":"1960","unstructured":"Press S. Hoigne\u2019s syndrome. Am J Dis Child. 1960;1985(139):1073\u20134.","journal-title":"Am J Dis Child."},{"key":"578_CR85","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1001\/archpedi.1985.02140060017014","volume":"139","author":"TJ Silber","year":"1985","unstructured":"Silber TJ, D\u2019Angelo L. Psychosis and seizures following the injection of penicillin G procaine: Hoigne\u2019s syndrome. Am J Dis Child. 1985;139:335\u20137.","journal-title":"Am J Dis Child."},{"key":"578_CR86","first-page":"6","volume":"140","author":"IG T\u00e9lessy","year":"1986","unstructured":"T\u00e9lessy IG. Hoigne\u2019s Syndrome. Am J Dis Child. 1986;140:6.","journal-title":"Am J Dis Child."},{"key":"578_CR87","first-page":"1317","volume":"145","author":"N Biddle","year":"1988","unstructured":"Biddle N, McCormack H. Panic disorder and the procaine in penicillin G. Am J Psychiatry. 1988;145:1317.","journal-title":"Am J Psychiatry."},{"key":"578_CR88","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1176\/ajp.111.9.699","volume":"111","author":"SB Cohen","year":"1955","unstructured":"Cohen SB. Psychosis resulting from penicillin hypersensitivity: report of a case and review of the literature. Am J Psychiatry. 1955;111:699\u2013702.","journal-title":"Am J Psychiatry."},{"key":"578_CR89","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.0954-6820.1959.tb14491.x","volume":"165","author":"A Bjornberg","year":"1959","unstructured":"Bjornberg A. Hallucinatory reactions in association with oral administration of probenecid-penicillin. Acta Med Scand. 1959;165:207\u201310.","journal-title":"Acta Med Scand."},{"key":"578_CR90","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1136\/bmj.1.5429.251-a","volume":"1","author":"JH Mitchell","year":"1965","unstructured":"Mitchell JH. Ampicillin intolerance. Br Med J. 1965;1:251.","journal-title":"Br Med J."},{"key":"578_CR91","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1742-1241.1996.tb09549.x","volume":"50","author":"IM Stell","year":"1996","unstructured":"Stell IM, Ojo OA. Amoxycillin-induced hallucinations\u2014a variant of Hoigne\u2019s syndrome? Br J Clin Pract. 1996;50:279.","journal-title":"Br J Clin Pract."},{"key":"578_CR92","doi-asserted-by":"crossref","first-page":"a2117","DOI":"10.1136\/bmj.a2117","volume":"337","author":"CL Bell","year":"2008","unstructured":"Bell CL, Watson B, Waring WS. Acute psychosis caused by co-amoxiclav. BMJ. 2008;337:a2117.","journal-title":"BMJ."},{"key":"578_CR93","first-page":"884","volume":"228","author":"DJ Oliver","year":"1984","unstructured":"Oliver DJ. Hallucinations associated with amoxycillin? A case report. Practitioner. 1984;228:884.","journal-title":"Practitioner."},{"key":"578_CR94","first-page":"793","volume":"99","author":"G Muro Uria","year":"1992","unstructured":"Muro Uria G, Abad Lecha E, Mart\u00edn Arias LH, Carvajal Garc\u00eda-Pando A. Increase in number of seizures following exposure to amoxycillin\/clavulanic acid. Med Clin (Barc). 1992;99:793\u20134.","journal-title":"Med Clin (Barc)."},{"key":"578_CR95","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0140-6736(82)90703-6","volume":"2","author":"M Serdaru","year":"1982","unstructured":"Serdaru M, Diquet B, Lhermitte F. Generalized seizures and ampicillin. Lancet. 1982;2:617\u20138.","journal-title":"Lancet."},{"key":"578_CR96","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.nephro.2008.10.004","volume":"5","author":"A-S Lemaire-Hurtel","year":"2009","unstructured":"Lemaire-Hurtel A-S, Gras-Champel V, Hary L, Masmoudi K, Massy Z, Andr\u00e9jak M. Les recommandations d\u2019adaptation posologique \u00e0 la fonction r\u00e9nale ne sont pas toujours suffisantes pour \u00e9viter la neurotoxicit\u00e9 des b\u00eatalactamines. Nephrol Ther. 2009;5:144\u20138.","journal-title":"Nephrol Ther."},{"key":"578_CR97","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1097\/00007611-198410000-00031","volume":"77","author":"T Hodgman","year":"1984","unstructured":"Hodgman T, Dasta JF, Armstrong DK, Visconti JA, Reilley TE. Ampicillin-associated seizures. South Med J. 1984;77:1323\u20135.","journal-title":"South Med J."},{"key":"578_CR98","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1034\/j.1398-9995.2003.00163.x","volume":"58","author":"O Thaunat","year":"2003","unstructured":"Thaunat O, Gilquin J, Lazareth I, Priollet P. Amoxicillin-induced aseptic meningo-encephalitis. Allergy. 2003;58:687\u20138.","journal-title":"Allergy."},{"key":"578_CR99","first-page":"157","volume":"3","author":"R Shahien","year":"2010","unstructured":"Shahien R, Vieksler V, Bowirrat A. Amoxicillin-induced aseptic meningoencephalitis. Int J Gen Med. 2010;3:157\u201362.","journal-title":"Int J Gen Med."},{"key":"578_CR100","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1212\/WNL.57.9.1734","volume":"57","author":"A Wittmann","year":"2001","unstructured":"Wittmann A, Wooten GF. Amoxicillin-induced aseptic meningitis. Neurology. 2001;57:1734.","journal-title":"Neurology."},{"key":"578_CR101","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1097\/00006454-198709000-00024","volume":"6","author":"ML Macknin","year":"1987","unstructured":"Macknin ML. Behavioral changes after amoxicillin-clavulanate. Pediatr Infect Dis J. 1987;6:873\u20134.","journal-title":"Pediatr Infect Dis J."},{"key":"578_CR102","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1136\/jnnp.74.5.690","volume":"74","author":"S Kastenbauer","year":"2003","unstructured":"Kastenbauer S, Pfister H-W, Wick M. No evidence of type 1 or type 3 hypersensitivity mechanism in amoxicillin\/clavulanic acid induced aseptic meningitis. J Neurol Neurosurg Psychiatry. 2003;74:690\u20131.","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"578_CR103","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.jocn.2010.07.122","volume":"18","author":"S Prieto-Gonz\u00e1lez","year":"2011","unstructured":"Prieto-Gonz\u00e1lez S, Escoda R, Coloma E, Grau JM. Amoxicillin-induced acute aseptic meningitis. J Clin Neurosci. 2011;18:443\u20134.","journal-title":"J Clin Neurosci."},{"key":"578_CR104","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1136\/bmj.318.7197.1521","volume":"318","author":"W Czerwenka","year":"1999","unstructured":"Czerwenka W, Gruenwald C, Conen D. Aseptic meningitis after treatment with amoxicillin. BMJ. 1999;318:1521.","journal-title":"BMJ."},{"key":"578_CR105","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1086\/527039","volume":"46","author":"CA Whyte","year":"2008","unstructured":"Whyte CA, Shivdat-Nanhoe R, Kramer P. A case of amoxicillin-induced meningitis. Clin Infect Dis. 2008;46:642.","journal-title":"Clin Infect Dis."},{"key":"578_CR106","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0025-7753(00)71197-3","volume":"114","author":"V Mateos","year":"2000","unstructured":"Mateos V, Calleja S, Jim\u00e9nez L, Su\u00e1rez-Moro R. Recurrent aseptic meningitis associated with amoxicillin\u2013clavulanic acid. Med Clin (Barc). 2000;114:79.","journal-title":"Med Clin (Barc)."},{"key":"578_CR107","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1056\/NEJM197702242960817","volume":"296","author":"AJ Malone","year":"1977","unstructured":"Malone AJ, Field S, Rosman J, Shemerdiak WP. Neurotoxic reaction to oxacillin. N Engl J Med. 1977;296:453.","journal-title":"N Engl J Med."},{"key":"578_CR108","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1177\/003693308302800218","volume":"28","author":"D McAreavey","year":"1983","unstructured":"McAreavey D, Redding PJ. Staphylococcal septicaemia complicated by probable cloxacillin neurotoxicity and by jaundice induced by fusidic acid. Scott Med J. 1983;28:179\u201380.","journal-title":"Scott Med J."},{"key":"578_CR109","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/0887-8994(88)90011-2","volume":"4","author":"BS Brozanski","year":"1988","unstructured":"Brozanski BS, Scher MS, Albright AL. Intraventricular nafcillin-induced seizures in a neonate. Pediatr Neurol. 1988;4:188\u201390.","journal-title":"Pediatr Neurol."},{"key":"578_CR110","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/S0140-6736(79)91032-8","volume":"313","author":"M Kallay","year":"1979","unstructured":"Kallay M, Tabechian H, Riley G, Chessin L. Neurotoxicity due to ticarcillin in patient with renal failure. Lancet. 1979;313:608\u20139.","journal-title":"Lancet."},{"key":"578_CR111","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1128\/AAC.26.3.310","volume":"26","author":"TM File","year":"1984","unstructured":"File TM, Tan JS, Salstrom S-J, Johnson LA, Douglas GF. Timentin versus piperacillin or moxalactam in the therapy of acute bacterial infections. Antimicrob Agents Chemother. 1984;26:310\u20133.","journal-title":"Antimicrob Agents Chemother."},{"key":"578_CR112","doi-asserted-by":"crossref","first-page":"165","DOI":"10.7326\/0003-4819-73-2-165","volume":"73","author":"TA Hoffman","year":"1970","unstructured":"Hoffman TA, Bullock WE. Carbenicillin therapy of Pseudomonas and other gram-negative bacillary infections. Ann Intern Med. 1970;73:165\u201371.","journal-title":"Ann Intern Med."},{"key":"578_CR113","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1001\/jama.1971.03190260056020","volume":"218","author":"A Whelton","year":"1971","unstructured":"Whelton A, Carter GG, Garth MA, Darwish MO, Walker WG. Carbenicillin-induced acidosis and seizures. JAMA. 1971;218:1942\u20133.","journal-title":"JAMA."},{"key":"578_CR114","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0022-510X(96)00119-0","volume":"140","author":"YC Park-Matsumoto","year":"1996","unstructured":"Park-Matsumoto YC, Tazawa T. Piperacillin-induced encephalopathy. J Neurol Sci. 1996;140:141\u20132.","journal-title":"J Neurol Sci."},{"key":"578_CR115","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1177\/000992289703600807","volume":"36","author":"CJ Malanga","year":"1997","unstructured":"Malanga CJ, Kokontis L, Mauzy S. Piperacillin-induced seizures. Clin Pediatr (Phila). 1997;36:475\u20138.","journal-title":"Clin Pediatr (Phila)."},{"key":"578_CR116","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/YCT.0b013e31816ba986","volume":"24","author":"T Saito","year":"2008","unstructured":"Saito T, Nakamura M, Watari M, Isse K. Tardive seizure and antibiotics: case reports and review of the literature. J ECT. 2008;24:275\u20136.","journal-title":"J ECT."},{"key":"578_CR117","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/s15010-009-8373-3","volume":"37","author":"W-T Huang","year":"2009","unstructured":"Huang W-T, Hsu Y-J, Chu P-L, Lin S-H. Neurotoxicity associated with standard doses of piperacillin in an elderly patient with renal failure. Infection. 2009;37:374\u20136.","journal-title":"Infection."},{"key":"578_CR118","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.seizure.2010.07.003","volume":"19","author":"JL Fern\u00e1ndez-Torre","year":"2010","unstructured":"Fern\u00e1ndez-Torre JL, Santos-S\u00e1nchez C, Pelayo AL. De novo generalised non-convulsive status epilepticus triggered by piperacillin\/tazobactam. Seizure. 2010;19:529\u201330.","journal-title":"Seizure."},{"key":"578_CR119","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1093\/ndt\/gfh048","volume":"19","author":"MKH Tong","year":"2004","unstructured":"Tong MKH, Siu Y-P, Yung C-Y, Kwan T-H. Piperacillin\/tazobactam-induced acute delirium in a peritoneal dialysis patient. Nephrol Dial Transpl. 2004;19:1341.","journal-title":"Nephrol Dial Transpl."},{"key":"578_CR120","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/hdi.12194","volume":"19","author":"PD Neves","year":"2015","unstructured":"Neves PD, Freitas FM, Kojima CA, Carmello BL, Bazan R, Barretti P, et al. Piperacillin\/tazobactam-induced neurotoxicity in a hemodialysis patient: a case report. Hemodial Int. 2015;19:143\u20135.","journal-title":"Hemodial Int."},{"key":"578_CR121","doi-asserted-by":"crossref","first-page":"327","DOI":"10.5414\/CNP58327","volume":"58","author":"N Bassilios","year":"2002","unstructured":"Bassilios N, Restoux A, Vincent F, Rondeau E, Sraer JD. Piperacillin\/Tazobactam inducing seizures in a hemodialysed patient. Clin Nephrol. 2002;58:327\u20138.","journal-title":"Clin Nephrol."},{"key":"578_CR122","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/MAJ.0b013e31803195e7","volume":"333","author":"C-S Lin","year":"2007","unstructured":"Lin C-S, Cheng C-J, Chou C-H, Lin S-H. Piperacillin\/tazobactam-induced seizure rapidly reversed by high flux hemodialysis in a patient on peritoneal dialysis. Am J Med Sci. 2007;333:181\u20134.","journal-title":"Am J Med Sci."},{"key":"578_CR123","doi-asserted-by":"publisher","unstructured":"Man BL, Fu YP. Piperacillin\/tazobactam-induced myoclonic jerks in a man with chronic renal failure. BMJ Case Rep. 2015. doi: 10.1136\/bcr-2015-210184 .","DOI":"10.1136\/bcr-2015-210184"},{"key":"578_CR124","first-page":"235","volume":"237","author":"JS Solomkin","year":"2003","unstructured":"Solomkin JS, Yellin AE, Rotstein OD, Christou NV, Dellinger EP, Tellado JM, et al. Ertapenem versus piperacillin\/tazobactam in the treatment of complicated intraabdominal infections: results of a double-blind, randomized comparative phase III trial. Ann Surg. 2003;237:235\u201345.","journal-title":"Ann Surg."},{"key":"578_CR125","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3109\/00365548.2012.728712","volume":"45","author":"M Saliho\u011flu","year":"2013","unstructured":"Saliho\u011flu M, Turhan V, \u00d6nem Y, Ulcay A, Uzun G, Ay H. Sudden hearing loss in a patient receiving piperacillin\/tazobactam and daptomycin for diabetic foot infection. Scand J Infect Dis. 2013;45:239\u201340.","journal-title":"Scand J Infect Dis."},{"key":"578_CR126","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/00000542-199003000-00028","volume":"72","author":"K Mackie","year":"1990","unstructured":"Mackie K, Pavlin EG. Recurrent paralysis following piperacillin administration. Anesthesiology. 1990;72:561\u20133.","journal-title":"Anesthesiology."},{"key":"578_CR127","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1345\/aph.1G526","volume":"40","author":"J Lambourne","year":"2006","unstructured":"Lambourne J, Kitchen J, Hughes C, Merry C. Piperacillin\/tazobactam-induced paresthesiae. Ann Pharmacother. 2006;40:977\u20139.","journal-title":"Ann Pharmacother."},{"key":"578_CR128","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1136\/jnnp.64.3.379","volume":"64","author":"RA Kristof","year":"1998","unstructured":"Kristof RA, Clusmann H, Koehler W, Fink KB, Schramm J. Treatment of accidental high dose intraventricular mezlocillin application by cerebrospinal fluid exchange. J Neurol Neurosurg Psychiatry. 1998;64:379\u201381.","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"578_CR129","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/BF03259866","volume":"2","author":"SJ Wroe","year":"1987","unstructured":"Wroe SJ, Ellershaw JE, Whittaker JA, Richens A. Focal motor status epilepticus following treatment with azlocillin and cefotaxime. Med Toxicol. 1987;2:233\u20134.","journal-title":"Med Toxicol."},{"key":"578_CR130","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1159\/000184921","volume":"48","author":"J Geyer","year":"1988","unstructured":"Geyer J, H\u00f6ffler D, Demers HG, Niemeyer R. Cephalosporin-induced encephalopathy in uremic patients. Nephron. 1988;48:237.","journal-title":"Nephron."},{"key":"578_CR131","first-page":"45","volume":"5","author":"G Heinecke","year":"1976","unstructured":"Heinecke G, H\u00f6ffler U, Finke K. Reversible encephalopathy following cephacetril therapy in high doses in a patient on chronic intermittent hemodialysis. Clin Nephrol. 1976;5:45\u20137.","journal-title":"Clin Nephrol."},{"key":"578_CR132","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1136\/bmj.283.6288.409","volume":"283","author":"R Taylor","year":"1981","unstructured":"Taylor R, Arze R, Gokal R, Stoddart JC. Cephaloridine encephalopathy. Br Med J (Clin Res Ed). 1981;283:409\u201310.","journal-title":"Br Med J (Clin Res Ed)."},{"key":"578_CR133","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/ana.410170221","volume":"17","author":"JD Schwankhaus","year":"1985","unstructured":"Schwankhaus JD, Masucci EF, Kurtzke JF. Cefazolin-induced encephalopathy in a uremic patient. Ann Neurol. 1985;17:211.","journal-title":"Ann Neurol."},{"key":"578_CR134","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1136\/bmj.4.5730.283","volume":"4","author":"R Gabriel","year":"1970","unstructured":"Gabriel R, Foord RD, Joekes AM. Reversible encephalopathy and acute renal failure after cephaloridine. Br Med J. 1970;4:283\u20134.","journal-title":"Br Med J."},{"key":"578_CR135","first-page":"429","volume":"89","author":"MJ Wu","year":"1978","unstructured":"Wu MJ, Narsette TA, Hussey JL, Weinstein AB, Wen SF. Cephalothin neurotoxicity in renal failure. Ann Intern Med. 1978;89:429.","journal-title":"Ann Intern Med."},{"key":"578_CR136","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1136\/bmj.299.6695.393-c","volume":"299","author":"AM Herd","year":"1989","unstructured":"Herd AM, Ross CA, Bhattacharya SK. Acute confusional state with postoperative intravenous cefazolin. BMJ. 1989;299:393\u20134.","journal-title":"BMJ."},{"key":"578_CR137","first-page":"627","volume":"37","author":"CA McDonald","year":"2003","unstructured":"McDonald CA, Addis S. Cephalosporin-induced psychosis. Aust N Z J Psychiatry. 2003;37:627\u20138.","journal-title":"Aust N Z J Psychiatry."},{"key":"578_CR138","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1159\/000184077","volume":"45","author":"S Josse","year":"1987","unstructured":"Josse S, Godin M, Fillastre JP. Cefazolin-induced encephalopathy in a uraemic patient. Nephron. 1987;45:72.","journal-title":"Nephron."},{"key":"578_CR139","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.5830\/CVJA-2015-002","volume":"26","author":"K Ceviker","year":"2015","unstructured":"Ceviker K, Kocaturk O, Demir D. An unusual cause of generalised seizure following cardiac surgery: with bolus cefazolin administration: case report. Cardiovasc J Afr. 2015;26:e11\u20133.","journal-title":"Cardiovasc J Afr."},{"key":"578_CR140","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1093\/clinids\/13.4.772","volume":"13","author":"A Ortiz","year":"1991","unstructured":"Ortiz A, Martin-Llonch N, Garr\u00f3n MP, Alberola ML, Caramelo C, Ortiz-Gonzalez A. Cefazolin-induced encephalopathy in uremic patients. Rev Infect Dis. 1991;13:772\u20133.","journal-title":"Rev Infect Dis."},{"key":"578_CR141","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.jadohealth.2006.05.005","volume":"39","author":"J Penttil\u00e4","year":"2006","unstructured":"Penttil\u00e4 J, Pasila K, Tiisala A, Sipil\u00e4inen P. Delirium in an adolescent patient during treatment with cephalexin. J Adolesc Health. 2006;39:782\u20133.","journal-title":"J Adolesc Health."},{"key":"578_CR142","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/BF01641056","volume":"3","author":"H Yoshioka","year":"1975","unstructured":"Yoshioka H, Nambu H, Fujita M, Uehara H. Convulsion following intrathecal cephaloridine. Infection. 1975;3:123\u20134.","journal-title":"Infection."},{"key":"578_CR143","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.clineuro.2008.06.007","volume":"110","author":"J-Y Choi","year":"2008","unstructured":"Choi J-Y, Seok HY, Lee S-H, Kim B-J, Park K-W, Jung K-Y. Epidural adhesiolysis complicated by cefazolin-induced status epilepticus: two cases. Clin Neurol Neurosurg. 2008;110:1041\u20133.","journal-title":"Clin Neurol Neurosurg."},{"key":"578_CR144","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1136\/bmj.2.5419.1238","volume":"2","author":"JM Murdoch","year":"1964","unstructured":"Murdoch JM, Speirs CF, Geddes AM, Wallace ET. Clinical trial of cephaloridine (Ceporin), a new broad-spectrum antibiotic derived from cephalosporin C. Br Med J. 1964;2:1238.","journal-title":"Br Med J."},{"key":"578_CR145","doi-asserted-by":"crossref","first-page":"970","DOI":"10.3171\/jns.1988.68.6.0970","volume":"68","author":"JP Manzella","year":"1988","unstructured":"Manzella JP, Paul RL, Butler IL. CNS toxicity associated with intraventricular injection of cefazolin: report of three cases. J Neurosurg. 1988;68:970\u20131.","journal-title":"J Neurosurg."},{"key":"578_CR146","doi-asserted-by":"crossref","first-page":"103","DOI":"10.36076\/ppj.2004\/7\/103","volume":"7","author":"MV Boswell","year":"2004","unstructured":"Boswell MV, Wolfe JR. Intrathecal cefazolin-induced seizures following attempted discography. Pain Physician. 2004;7:103\u20136.","journal-title":"Pain Physician."},{"key":"578_CR147","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1080\/02699050903196704","volume":"23","author":"Y Lee","year":"2009","unstructured":"Lee Y, Pyun S-B, Park EK, Youn SW. Persistent dysarthria after cefazolin-induced status epilepticus. Brain Inj. 2009;23:846\u201351.","journal-title":"Brain Inj."},{"key":"578_CR148","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/S0140-6736(82)92803-3","volume":"2","author":"J Sennesael","year":"1982","unstructured":"Sennesael J, Verbeelen D, Lauwers S. Ototoxicity associated with cephalexin in two patients with renal failure. Lancet. 1982;2:1154\u20135.","journal-title":"Lancet."},{"key":"578_CR149","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1001\/jama.1971.03180330074022","volume":"216","author":"U Mintz","year":"1971","unstructured":"Mintz U, Liberman UA, de Vries A. Parkinsonism syndrome due to cephaloridine. JAMA. 1971;216:1200.","journal-title":"JAMA."},{"key":"578_CR150","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.psym.2011.01.016","volume":"52","author":"L Denysenko","year":"2011","unstructured":"Denysenko L, Nicolson SE. Cefoxitin and ciprofloxacin neurotoxicity and catatonia in a patient on hemodialysis. Psychosomatics. 2011;52:379\u201383.","journal-title":"Psychosomatics."},{"key":"578_CR151","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/S0140-6736(84)92425-5","volume":"1","author":"W Vincken","year":"1984","unstructured":"Vincken W. Psychotic reaction to cefuroxime. Lancet. 1984;1:965.","journal-title":"Lancet."},{"key":"578_CR152","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1212\/WNL.50.6.1873","volume":"50","author":"YO Herishanu","year":"1998","unstructured":"Herishanu YO, Zlotnik M, Mostoslavsky M, Podgaietski M, Frisher S, Wirguin I. Cefuroxime-induced encephalopathy. Neurology. 1998;50:1873\u20135.","journal-title":"Neurology."},{"key":"578_CR153","first-page":"629","volume":"5","author":"CS Tse","year":"1986","unstructured":"Tse CS, Madura AJ, Vera FH. Suspected cefonicid-induced seizure. Clin Pharm. 1986;5:629.","journal-title":"Clin Pharm."},{"key":"578_CR154","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s00228-004-0787-3","volume":"60","author":"G Br\u00f6ssner","year":"2004","unstructured":"Br\u00f6ssner G, Engelhardt K, Beer R, Pfausler B, Georgopoulos A, Schmutzhard E. Accidental intrathecal infusion of cefotiam: clinical presentation and management. Eur J Clin Pharmacol. 2004;60:373\u20135.","journal-title":"Eur J Clin Pharmacol."},{"key":"578_CR155","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.3346\/jkms.2012.27.9.1120","volume":"27","author":"KB Kim","year":"2012","unstructured":"Kim KB, Kim SM, Park W, Kim JS, Kwon SK, Kim H-Y. Ceftriaxone-induced neurotoxicity: case report, pharmacokinetic considerations, and literature review. J Korean Med Sci. 2012;27:1120.","journal-title":"J Korean Med Sci."},{"key":"578_CR156","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.pediatrneurol.2003.07.006","volume":"30","author":"AK Chedrawi","year":"2004","unstructured":"Chedrawi AK, Gharaybeh SI, Al-Ghwery SA, Al-Mohaimeed SA, Alshahwan SA. Cephalosporin-induced nonconvulsive status epilepticus in a uremic child. Pediatr Neurol. 2004;30:135\u20139.","journal-title":"Pediatr Neurol."},{"key":"578_CR157","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1159\/000185817","volume":"54","author":"J Pascual","year":"1990","unstructured":"Pascual J, Lia\u00f1o F, Ortu\u00f1o J. Cefotaxime-induced encephalopathy in an uremic patient. Nephron. 1990;54:92.","journal-title":"Nephron."},{"key":"578_CR158","doi-asserted-by":"crossref","first-page":"124","DOI":"10.4103\/0253-7613.91884","volume":"44","author":"N Sharma","year":"2012","unstructured":"Sharma N, Gupta A, Batish S. Ceftriaxone-induced acute reversible encephalopathy in a patient with enteric fever. Indian J Pharmacol. 2012;44:124.","journal-title":"Indian J Pharmacol."},{"key":"578_CR159","first-page":"322","volume":"140","author":"JP Vincent","year":"1989","unstructured":"Vincent JP, Dervanian P, Bodak A. Encephalopathy caused by cefotaxime. A case in an aged patient with renal failure. Ann Med Interne (Paris). 1989;140:322.","journal-title":"Ann Med Interne (Paris)"},{"key":"578_CR160","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1177\/106002808602000310","volume":"20","author":"I Cho","year":"1986","unstructured":"Cho I, Bertoni JM, Hopkins L. Moxalactam myoclonus, seizures, and encephalopathy. Drug Intell Clin Pharm. 1986;20:223\u20134.","journal-title":"Drug Intell Clin Pharm."},{"key":"578_CR161","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/MAJ.0b013e3181ec063b","volume":"340","author":"Y Sato","year":"2010","unstructured":"Sato Y, Morita H, Wakasugi H, Iijima S, Kawashima E, Wakayama Y, et al. Reversible choreoathetosis after the administration of ceftriaxone sodium in patients with end-stage renal disease. Am J Med Sci. 2010;340:382\u20134.","journal-title":"Am J Med Sci."},{"key":"578_CR162","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/PEC.0b013e31823f252d","volume":"28","author":"E Bayram","year":"2012","unstructured":"Bayram E, Bayram MT, Hiz S, Turkmen M. Cefixime-induced oculogyric crisis. Pediatr Emerg Care. 2012;28:55\u20136.","journal-title":"Pediatr Emerg Care."},{"key":"578_CR163","first-page":"72","volume":"67","author":"R Roncon-Albuquerque","year":"2009","unstructured":"Roncon-Albuquerque R, Pires I, Martins R, Real R, Sousa G, von Hafe P. Ceftriaxone-induced acute reversible encephalopathy in a patient treated for a urinary tract infection. Neth J Med. 2009;67:72\u20135.","journal-title":"Neth J Med."},{"key":"578_CR164","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1212\/01.wnl.0000187079.12413.6a","volume":"65","author":"FJ Capparelli","year":"2005","unstructured":"Capparelli FJ, Diaz MF, Hlavnika A, Wainsztein NA, Leiguarda R, Del Castillo ME. Cefepime- and cefixime-induced encephalopathy in a patient with normal renal function. Neurology. 2005;65:1840.","journal-title":"Neurology."},{"key":"578_CR165","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s10072-011-0668-3","volume":"33","author":"F Anzellotti","year":"2012","unstructured":"Anzellotti F, Ricciardi L, Monaco D, Ciccocioppo F, Borrelli I, Zhuzhuni H, et al. Cefixime-induced nonconvulsive status epilepticus. Neurol Sci. 2012;33:325\u20139.","journal-title":"Neurol Sci."},{"key":"578_CR166","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s10072-010-0425-z","volume":"32","author":"S Pro","year":"2011","unstructured":"Pro S, Randi F, Pulitano P, Vicenzini E, Mecarelli O. Reversible encephalopathy induced by cefoperazone: a case report monitored with EEG. Neurol Sci. 2011;32:465\u20137.","journal-title":"Neurol Sci."},{"key":"578_CR167","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1128\/AAC.20.1.88","volume":"20","author":"WK Livingston","year":"1981","unstructured":"Livingston WK, Elliott AM, Dismukes WE, Avent CK, Cobbs CG. Clinical evaluation of moxalactam. Antimicrob Agents Chemother. 1981;20:88\u201397.","journal-title":"Antimicrob Agents Chemother."},{"key":"578_CR168","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s00776-007-1116-3","volume":"12","author":"Y Takahashi","year":"2007","unstructured":"Takahashi Y, Ohnishi H, Oda K, Nakamura T. Bilateral acetabular fractures secondary to a seizure attack caused by antibiotic medicine. J Orthop Sci. 2007;12:308\u201310.","journal-title":"J Orthop Sci."},{"key":"578_CR169","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s10157-008-0115-9","volume":"13","author":"S Ozturk","year":"2009","unstructured":"Ozturk S, Kocabay G, Topcular B, Yazici H, Cagatay AA, Bahat G, et al. Non-convulsive status epilepticus following antibiotic therapy as a cause of unexplained loss of consciousness in patients with renal failure. Clin Exp Nephrol. 2009;13:138\u201344.","journal-title":"Clin Exp Nephrol."},{"key":"578_CR170","first-page":"926","volume":"5","author":"LH Hoffman","year":"1986","unstructured":"Hoffman LH. Neurotoxicity associated with moxalactam. Clin Pharm. 1986;5:926\u20138.","journal-title":"Clin Pharm."},{"key":"578_CR171","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.revmed.2013.02.027","volume":"35","author":"A Landais","year":"2014","unstructured":"Landais A, Marty N, Bessis D, Pages M, Blard J-M. Hoigne syndrome following an intravenous injection of ceftriaxone: a case report. Rev Med Interne. 2014;35:199\u2013201.","journal-title":"Rev Med Interne"},{"key":"578_CR172","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1177\/0883073807304016","volume":"22","author":"W Nakajima","year":"2007","unstructured":"Nakajima W, Ishida A, Takahashi M, Sato Y, Ito T, Takada G. Aseptic meningitis associated with cephalosporins in an infant with trisomy 21. J Child Neurol. 2007;22:780\u20132.","journal-title":"J Child Neurol."},{"key":"578_CR173","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/ana.410370617","volume":"37","author":"GB Creel","year":"1995","unstructured":"Creel GB, Hurtt M. Cephalosporin-induced recurrent aseptic meningitis. Ann Neurol. 1995;37:815\u20137.","journal-title":"Ann Neurol."},{"key":"578_CR174","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1080\/10428190601039755","volume":"48","author":"MG Martin","year":"2007","unstructured":"Martin MG. Encephalopathy with myoclonic jerks resulting from ceftazidime therapy: an under-recognized potential side-effect when treating febrile neutropenia. Leuk Lymphoma. 2007;48:413\u20134.","journal-title":"Leuk Lymphoma."},{"key":"578_CR175","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1159\/000077370","volume":"49","author":"A Primavera","year":"2004","unstructured":"Primavera A, Cocito L, Audenino D. Nonconvulsive status epilepticus during cephalosporin therapy. Neuropsychobiology. 2004;49:218\u201322.","journal-title":"Neuropsychobiology."},{"key":"578_CR176","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1136\/jnnp.55.4.333","volume":"55","author":"GD Jackson","year":"1992","unstructured":"Jackson GD, Berkovic SF. Ceftazidime encephalopathy: absence status and toxic hallucinations. J Neurol Neurosurg Psychiatry. 1992;55:333\u20134.","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"578_CR177","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1177\/089686089401400424","volume":"14","author":"WC Lye","year":"1994","unstructured":"Lye WC, Leong SO. Neurotoxicity associated with intraperitoneal ceftazidime therapy in a CAPD patient. Perit Dial Int. 1994;14:408.","journal-title":"Perit Dial Int."},{"key":"578_CR178","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1212\/WNL.41.12.2008","volume":"41","author":"RE Hillsley","year":"1991","unstructured":"Hillsley RE, Massey EW. Truncal asterixis associated with ceftazidime, a third-generation cephalosporin. Neurology. 1991;41:2008.","journal-title":"Neurology."},{"key":"578_CR179","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/j.1875-9114.1991.tb04302.x","volume":"11","author":"RA Slaker","year":"1991","unstructured":"Slaker RA, Danielson B. Neurotoxicity associated with ceftazidime therapy in geriatric patients with renal dysfunction. Pharmacotherapy. 1991;11:351\u20132.","journal-title":"Pharmacotherapy."},{"key":"578_CR180","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1001\/archinte.1994.00420050158014","volume":"154","author":"AD Klion","year":"1994","unstructured":"Klion AD, Kallsen J, Cowl CT, Nauseef WM. Ceftazidime-related nonconvulsive status epilepticus. Arch Intern Med. 1994;154:586\u20139.","journal-title":"Arch Intern Med."},{"key":"578_CR181","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1001\/archneur.1988.00520330010002","volume":"45","author":"MA Douglas","year":"1988","unstructured":"Douglas MA, Quandt CM, Stanley DA. Ceftazidime-induced encephalopathy in a patient with renal impairment. Arch Neurol. 1988;45:936\u20137.","journal-title":"Arch Neurol."},{"key":"578_CR182","doi-asserted-by":"crossref","first-page":"E20","DOI":"10.1212\/01.wnl.0000190256.30385.13","volume":"66","author":"S Chan","year":"2006","unstructured":"Chan S, Turner MR, Young L, Gregory R. Cephalosporin-induced myoclonus. Neurology. 2006;66:E20.","journal-title":"Neurology."},{"key":"578_CR183","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ijid.2003.09.003","volume":"8","author":"GK Dakdouki","year":"2004","unstructured":"Dakdouki GK, Al-Awar GN. Cefepime-induced encephalopathy. Int J Infect Dis. 2004;8:59\u201361.","journal-title":"Int J Infect Dis."},{"key":"578_CR184","first-page":"608","volume":"53","author":"E Basto","year":"1998","unstructured":"Basto E, Sollet JP, Bleichner G, Eurin B. Fatal encephalopathy induced by ceftazidime. Th\u00e9rapie. 1998;53:608\u201310.","journal-title":"Th\u00e9rapie"},{"key":"578_CR185","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1080\/15563650600671753","volume":"44","author":"S Vannaprasaht","year":"2006","unstructured":"Vannaprasaht S, Tawalee A, Mayurasakorn N, Yodwut C, Bansong R, Reungjui S, et al. Ceftazidime overdose-related nonconvulsive status epilepticus after intraperitoneal instillation. Clin Toxicol. 2006;44:383\u20136.","journal-title":"Clin Toxicol."},{"key":"578_CR186","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/ndt\/gfg476","volume":"19","author":"C-L Chuang","year":"2004","unstructured":"Chuang C-L, Chen K-P, Kwan S-Y, Yang W-C. Creutzfeldt\u2013Jakob-like EEG in a patient with end-stage renal failure. Nephrol Dial Transplant. 2004;19:252\u20134.","journal-title":"Nephrol Dial Transplant."},{"key":"578_CR187","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1592\/phco.23.3.369.32100","volume":"23","author":"KM Chow","year":"2003","unstructured":"Chow KM, Szeto CC, Hui AC-F, Wong TY-H, Li PK-T. Retrospective review of neurotoxicity induced by cefepime and ceftazidime. Pharmacotherapy. 2003;23:369\u201373.","journal-title":"Pharmacotherapy."},{"key":"578_CR188","first-page":"435","volume":"49","author":"E Chetaille","year":"1994","unstructured":"Chetaille E, Masmoudi K, Dimier-David L, Hary L, Schmit JL, Andrejak M. Convulsions associated with the administration of excessive dose of ceftazidime in patients with renal failure. Th\u00e9rapie. 1994;49:435\u20138.","journal-title":"Th\u00e9rapie"},{"key":"578_CR189","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1136\/bmj.297.6652.858-a","volume":"297","author":"MF al-Zahawi","year":"1988","unstructured":"al-Zahawi MF, Sprott MS, Hendrick DJ. Hallucinations in association with ceftazidime. BMJ. 1988;297:858.","journal-title":"BMJ."},{"key":"578_CR190","first-page":"167","volume":"53","author":"E Chetaille","year":"1998","unstructured":"Chetaille E, Hary L, de Cagny B, Gras-Champel V, Decocq G, Andr\u00e9jak M. Convulsive crisis associated with an overdose of cefepime. Th\u00e9rapie. 1998;53:167\u20138.","journal-title":"Th\u00e9rapie"},{"key":"578_CR191","doi-asserted-by":"crossref","first-page":"4360","DOI":"10.1128\/AAC.01595-08","volume":"54","author":"F Lamoth","year":"2010","unstructured":"Lamoth F, Buclin T, Pascual A, Vora S, Bolay S, Decosterd LA, et al. High cefepime plasma concentrations and neurological toxicity in febrile neutropenic patients with mild impairment of renal function. Antimicrob Agents Chemother. 2010;54:4360\u20137.","journal-title":"Antimicrob Agents Chemother."},{"key":"578_CR192","doi-asserted-by":"crossref","first-page":"R264","DOI":"10.1186\/cc13094","volume":"17","author":"JE Fugate","year":"2013","unstructured":"Fugate JE, Kalimullah EA, Hocker SE, Clark SL, Wijdicks EF, Rabinstein AA. Cefepime neurotoxicity in the intensive care unit: a cause of severe, underappreciated encephalopathy. Crit Care. 2013;17:R264.","journal-title":"Crit Care."},{"key":"578_CR193","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1684\/epd.2013.0614","volume":"15","author":"JL Fern\u00e1ndez-Torre","year":"2013","unstructured":"Fern\u00e1ndez-Torre JL, Hern\u00e1ndez-Hern\u00e1ndez MA, Rodr\u00edguez-Borreg\u00e1n JC, Gonz\u00e1lez-Quintanilla V. Usefulness of bilateral bispectral index (BIS) monitoring in a comatose patient with myoclonic status epilepticus secondary to cefepime. Epileptic Disord. 2013;15:444\u201350.","journal-title":"Epileptic Disord."},{"key":"578_CR194","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.yebeh.2005.09.010","volume":"8","author":"R Maganti","year":"2006","unstructured":"Maganti R, Jolin D, Rishi D, Biswas A. Nonconvulsive status epilepticus due to cefepime in a patient with normal renal function. Epilepsy Behav. 2006;8:312\u20134.","journal-title":"Epilepsy Behav."},{"key":"578_CR195","doi-asserted-by":"crossref","first-page":"827","DOI":"10.3109\/00365548.2011.581308","volume":"43","author":"VGR Gangireddy","year":"2011","unstructured":"Gangireddy VGR, Mitchell LC, Coleman T. Cefepime neurotoxicity despite renal adjusted dosing. Scand J Infect. Dis. 2011;43:827\u20139.","journal-title":"Scand J Infect. Dis."},{"key":"578_CR196","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3109\/00365548.2013.878032","volume":"46","author":"T Ugai","year":"2014","unstructured":"Ugai T, Morisaki K, Tsuda K, Sugihara H, Nishida Y, Yamakura M, et al. Cefepime-induced encephalopathy in patients with haematological malignancies: clinical features and risk factors. Scand J Infect Dis. 2014;46:272\u20139.","journal-title":"Scand J Infect Dis."},{"key":"578_CR197","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/sj.bmt.1704314","volume":"33","author":"E Plensa","year":"2004","unstructured":"Plensa E, Gallardo E, Ribera J-M, Batlle M, Oriol A, Costa J. Nonconvulsive status epilepticus associated with cefepime in a patient undergoing autologous stem cell transplantation. Bone Marrow Transplant. 2004;33:119\u201320.","journal-title":"Bone Marrow Transplant."},{"key":"578_CR198","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/s00134-001-1170-9","volume":"28","author":"D Chatellier","year":"2002","unstructured":"Chatellier D, Jourdain M, Mangalaboyi J, Ader F, Chopin C, Derambure P, et al. Cefepime-induced neurotoxicity: an underestimated complication of antibiotherapy in patients with acute renal failure. Intensive Care Med. 2002;28:214\u20137.","journal-title":"Intensive Care Med."},{"key":"578_CR199","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1111\/j.1528-1167.2005.16305.x","volume":"46","author":"JL Fern\u00e1ndez-Torre","year":"2005","unstructured":"Fern\u00e1ndez-Torre JL, Mart\u00ednez-Mart\u00ednez M, Gonz\u00e1lez-Rato J, Maestro I, Alonso I, Rodrigo E, et al. Cephalosporin-induced nonconvulsive status epilepticus: clinical and electroencephalographic features. Epilepsia. 2005;46:1550\u20132.","journal-title":"Epilepsia."},{"key":"578_CR200","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1093\/jac\/dkn256","volume":"62","author":"J Bresson","year":"2008","unstructured":"Bresson J, Paugam-Burtz C, Josserand J, Bardin C, Mantz J, Pease S. Cefepime overdosage with neurotoxicity recovered by high-volume haemofiltration. J Antimicrob Chemother. 2008;62:849\u201350.","journal-title":"J Antimicrob Chemother."},{"key":"578_CR201","first-page":"181","volume":"29","author":"C Mart\u00edn Herrera","year":"2009","unstructured":"Mart\u00edn Herrera C, Navarro M. Cefepime-induced encephalopathy in patients with renal failure. Nefrologia. 2009;29:181.","journal-title":"Nefrologia."},{"key":"578_CR202","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1093\/jac\/dks012","volume":"67","author":"C Durand-Maugard","year":"2012","unstructured":"Durand-Maugard C, Lemaire-Hurtel A-S, Gras-Champel V, Hary L, Maizel J, Prud\u2019homme-Bernardy A, et al. Blood and CSF monitoring of cefepime-induced neurotoxicity: nine case reports. J Antimicrob Chemother. 2012;67:1297\u20139.","journal-title":"J Antimicrob Chemother."},{"key":"578_CR203","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1212\/WNL.54.11.2153","volume":"54","author":"S Dixit","year":"2000","unstructured":"Dixit S, Kurle P, Buyan-Dent L, Sheth RD. Status epilepticus associated with cefepime. Neurology. 2000;54:2153\u20135.","journal-title":"Neurology."},{"key":"578_CR204","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s12028-008-9166-8","volume":"10","author":"F Thabet","year":"2009","unstructured":"Thabet F, Al Maghrabi M, Al Barraq A, Tabarki B. Cefepime-induced nonconvulsive status epilepticus: case report and review. Neurocrit Care. 2009;10:347\u201351.","journal-title":"Neurocrit Care."},{"key":"578_CR205","doi-asserted-by":"crossref","first-page":"39","DOI":"10.14581\/jer.13008","volume":"3","author":"A Kim","year":"2013","unstructured":"Kim A, Kim J-E, Paek Y-M, Hong K-S, Cho Y-J, Cho J-Y, et al. Cefepime-induced non-convulsive status epilepticus (NCSE). J Epilepsy Res. 2013;3:39.","journal-title":"J Epilepsy Res."},{"key":"578_CR206","doi-asserted-by":"crossref","first-page":"159","DOI":"10.5535\/arm.2012.36.1.159","volume":"36","author":"S-Y Kim","year":"2012","unstructured":"Kim S-Y, Lee I-S, Park SL, Lee J. Cefepime neurotoxicity in patients with renal insufficiency. Ann Rehabil Med. 2012;36:159.","journal-title":"Ann Rehabil Med."},{"key":"578_CR207","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3904\/kjim.2012.27.3.367","volume":"27","author":"JY Lee","year":"2012","unstructured":"Lee JY, Kang KP, Kim W, Park SK, Lee S. An overlooked cause of impaired consciousness in a hemodialysis patient. Korean J Intern Med. 2012;27:367.","journal-title":"Korean J Intern Med."},{"key":"578_CR208","doi-asserted-by":"crossref","first-page":"E18","DOI":"10.1002\/jhm.408","volume":"5","author":"H Lichaa","year":"2010","unstructured":"Lichaa H, Rachoin J-S, Cerceo E, Rajput V, Surkis W. Cefepime: an underrecognized cause of nonconvulsive status epilepticus. J Hosp Med. 2010;5:E18\u20139.","journal-title":"J Hosp Med."},{"key":"578_CR209","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/S0035-3787(07)74189-9","volume":"163","author":"N Sagot","year":"2007","unstructured":"Sagot N, De Broucker T, Esquivel-Walls E, Rouvel A. Pseudoperiodic EEG heralding a cefepime-induced encephalopathy. Rev Neurol (Paris). 2007;163:1122\u20133.","journal-title":"Rev Neurol (Paris)."},{"key":"578_CR210","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1212\/WNL.55.11.1756","volume":"55","author":"JT Fishbain","year":"2000","unstructured":"Fishbain JT, Monahan TP, Canonico MM. Cerebral manifestations of cefepime toxicity in a dialysis patient. Neurology. 2000;55:1756\u20137.","journal-title":"Neurology."},{"key":"578_CR211","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1345\/aph.1D322","volume":"38","author":"S Abanades","year":"2004","unstructured":"Abanades S. Reversible coma secondary to cefepime neurotoxicity. Ann Pharmacother. 2004;38:606\u20138.","journal-title":"Ann Pharmacother."},{"key":"578_CR212","doi-asserted-by":"crossref","first-page":"450","DOI":"10.47102\/annals-acadmedsg.V36N6p450","volume":"36","author":"DA Silva De","year":"2007","unstructured":"De Silva DA, Pan ABS, Lim S-H. Cefepime-induced encephalopathy with triphasic waves in three Asian patients. Ann Acad Med (Singap). 2007;36:450\u20131.","journal-title":"Ann Acad Med (Singap)."},{"key":"578_CR213","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1590\/S0004-282X2005000100016","volume":"63","author":"JA Bragatti","year":"2005","unstructured":"Bragatti JA, Rossato R, Ziomkowski S, Kliemann FAD. Cefepime-induced encephalopathy: clinical and electroencephalographic features in seven patients. Arq Neuropsiquiatr. 2005;63:87\u201392.","journal-title":"Arq Neuropsiquiatr."},{"key":"578_CR214","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jcma.2011.01.017","volume":"74","author":"C-J Lin","year":"2011","unstructured":"Lin C-J, Chen S-P, Wang S-J, Fuh J-L. Cefepime-related encephalopathy in peritoneal dialysis patients. J Chin Med Assoc. 2011;74:87\u201390.","journal-title":"J Chin Med Assoc."},{"key":"578_CR215","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1053\/ajkd.2001.26105","volume":"38","author":"KM Chow","year":"2001","unstructured":"Chow KM, Wang AY-M, Hui AC-F, Wong TY-H, Szeto CC, Li PK-T. Nonconvulsive status epilepticus in peritoneal dialysis patients. Am J Kidney Dis. 2001;38:400\u20135.","journal-title":"Am J Kidney Dis."},{"key":"578_CR216","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.pediatrneurol.2012.08.017","volume":"47","author":"LC Landgrave","year":"2012","unstructured":"Landgrave LC, Lock JL, Whitmore JM, Belcher CE. Pediatric cefepime neurotoxicity. Pediatr Neurol. 2012;47:458\u201360.","journal-title":"Pediatr Neurol."},{"key":"578_CR217","doi-asserted-by":"publisher","unstructured":"Balderia PG, Chandorkar A, Kim Y, Patnaik S, Sloan J, Newman GC. Dosing cefepime for renal function does not completely prevent neurotoxicity in a patient with kidney transplant. J Patient Saf. 2015. doi: 10.1097\/PTS.0000000000000225 .","DOI":"10.1097\/PTS.0000000000000225"},{"key":"578_CR218","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1179\/joc.2009.21.4.452","volume":"21","author":"T Shaheen","year":"2009","unstructured":"Shaheen T, Volles D, Calland F, Sifri CD, Mytinger J, Hagspiel K, et al. Cefepime-associated status epilepticus in an ICU Patient with renal failure. J Chemother. 2009;21:452\u20134.","journal-title":"J Chemother."},{"key":"578_CR219","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0014-2565(04)71527-1","volume":"204","author":"MJ S\u00e1nchez-Bail\u00e9n","year":"2004","unstructured":"S\u00e1nchez-Bail\u00e9n MJ, Navarro Ciruelos N, Rovira Garc\u00eda-Marr\u00f3n R, Angl\u00e8s Coll R. Cefepime-associated encephalopathy in a patient with septic shock and renal failure. Rev Clin Esp. 2004;204:501\u20132.","journal-title":"Rev Clin Esp"},{"key":"578_CR220","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/hdi.12198","volume":"19","author":"L-Y Mani","year":"2015","unstructured":"Mani L-Y, Kissling S, Viceic D, Vogt B, Burnier M, Buclin T, et al. Intermittent hemodialysis treatment in cefepime-induced neurotoxicity: case report, pharmacokinetic modeling, and review of the literature. Hemodial Int. 2015;19:333\u201343.","journal-title":"Hemodial Int."},{"key":"578_CR221","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/j.1445-5994.2012.02800.x","volume":"42","author":"A McNally","year":"2012","unstructured":"McNally A, Pithie A, Jardine D. Cefepime: a rare cause of encephalopathy: Letters to the Editor. Intern Med J. 2012;42:732\u20133.","journal-title":"Intern Med J."},{"key":"578_CR222","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1093\/ndt\/14.9.2265","volume":"14","author":"KM Wong","year":"1999","unstructured":"Wong KM, Chan WK, Chan YH, Li CS. Cefepime-related neurotoxicity in a haemodialysis patient. Nephrol Dial Transpl. 1999;14:2265\u20136.","journal-title":"Nephrol Dial Transpl."},{"key":"578_CR223","first-page":"526","volume":"21","author":"EO Garces","year":"2008","unstructured":"Garces EO, Andrade de Anzambuja MF, da Silva D, Bragatti JA, Jacoby T, Saldanha Thom\u00e9 F. Renal failure is a risk factor for cefepime-induced encephalopathy. J Nephrol. 2008;21:526\u201334.","journal-title":"J Nephrol."},{"key":"578_CR224","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1212\/CPJ.0b013e31823b4e5d","volume":"1","author":"S Hocker","year":"2011","unstructured":"Hocker S, Rabinstein AA. Cefepime neurotoxicity can mimic postanoxic coma with myoclonic status epilepticus. Neurol Clin Pract. 2011;1:73\u20134.","journal-title":"Neurol Clin Pract."},{"key":"578_CR225","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1592\/phco.26.8.1169","volume":"26","author":"S Lam","year":"2006","unstructured":"Lam S, Gomolin IH. Cefepime neurotoxicity: case report, pharmacokinetic considerations, and literature review. Pharmacotherapy. 2006;26:1169\u201374.","journal-title":"Pharmacotherapy."},{"key":"578_CR226","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1093\/ndt\/gfm713","volume":"23","author":"J Sonck","year":"2007","unstructured":"Sonck J, Laureys G, Verbeelen D. The neurotoxicity and safety of treatment with cefepime in patients with renal failure. Nephrol Dial Transplant. 2007;23:966\u201370.","journal-title":"Nephrol Dial Transplant."},{"key":"578_CR227","first-page":"269","volume":"15","author":"C Lin","year":"2006","unstructured":"Lin C, Chen Y, Po HL, Hseuh I. Acute neurological deficits caused by cefipime: a case report and review of literature. Acta Neurol Taiwan. 2006;15:269.","journal-title":"Acta Neurol Taiwan."},{"key":"578_CR228","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s11096-013-9799-3","volume":"35","author":"A Tanaka","year":"2013","unstructured":"Tanaka A, Takechi K, Watanabe S, Tanaka M, Suemaru K, Araki H. Comparison of the prevalence of convulsions associated with the use of cefepime and meropenem. Int J Clin Pharm. 2013;35:683\u20137.","journal-title":"Int J Clin Pharm."},{"key":"578_CR229","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1001\/archneurol.2011.204","volume":"68","author":"G Naeije","year":"2011","unstructured":"Naeije G. Continuous epileptiform discharges in patients treated with cefepime or meropenem. Arch Neurol. 2011;68:1303.","journal-title":"Arch Neurol."},{"key":"578_CR230","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0987-7053(00)00234-3","volume":"30","author":"P Jallon","year":"2000","unstructured":"Jallon P, Fankhauser L, Du Pasquier R, Coeytaux A, Picard F, Hefft S, et al. Severe but reversible encephalopathy associated with cefepime. Neurophysiol Clin. 2000;30:383\u20136.","journal-title":"Neurophysiol Clin."},{"key":"578_CR231","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1590\/0004-282X20140094","volume":"72","author":"V Passarelli","year":"2014","unstructured":"Passarelli V, da Concei\u00e7\u00e3o MPOM, Tr\u00e9s ES, Alves Junior JF, Baldocchi MA. Stimulus-induced rhythmic, periodic, or ictal discharges (SIRPDs) associated with seizures in cefepime neurotoxicity. Arq Neuropsiquiatr. 2014;72:643\u20134.","journal-title":"Arq Neuropsiquiatr."},{"key":"578_CR232","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s00467-003-1333-8","volume":"19","author":"H Alpay","year":"2004","unstructured":"Alpay H, Altun O, Biyikli NK. Cefepime-induced non-convulsive status epilepticus in a peritoneal dialysis patient. Pediatr Nephrol. 2004;19:445\u20137.","journal-title":"Pediatr Nephrol."},{"key":"578_CR233","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.7326\/0003-4819-135-11-200112040-00027","volume":"135","author":"F Barbey","year":"2001","unstructured":"Barbey F, Bugnon D, Wauters JP. Severe neurotoxicity of cefepime in uremic patients. Ann Intern Med. 2001;135:1011.","journal-title":"Ann Intern Med."},{"key":"578_CR234","first-page":"554","volume":"20","author":"A Saurina","year":"2000","unstructured":"Saurina A, Vera M, Pou M, L\u00f3pez Pedret J, Darnell A, Campistol JM, et al. Non-convulsive status epilepticus secondary to adjusted cefepime doses in patients with chronic renal failure. Nefrologia. 2000;20:554\u20138.","journal-title":"Nefrologia"},{"key":"578_CR235","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1590\/s1679-45082010rc1121","volume":"8","author":"FMS Coelho","year":"2010","unstructured":"Coelho FMS, Bernstein M, Yokota PKO, Coelho RME, Wachemberg M, de Sampaio LPB, et al. Cefepime-induced encephalopathy in patient without renal failure. Einstein (Sao Paulo). 2010;8:358\u201360.","journal-title":"Einstein (Sao Paulo)."},{"key":"578_CR236","doi-asserted-by":"crossref","first-page":"R51","DOI":"10.1186\/cc8941","volume":"14","author":"TM Chapuis","year":"2010","unstructured":"Chapuis TM, Giannoni E, Majcherczyk PA, Chiol\u00e9ro R, Schaller M-D, Berger MM, et al. Prospective monitoring of cefepime in intensive care unit adult patients. Crit Care. 2010;14:R51.","journal-title":"Crit Care."},{"key":"578_CR237","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jfma.2013.05.002","volume":"114","author":"Y-M Chang","year":"2015","unstructured":"Chang Y-M. Cefepime-induced nonconvulsive status epilepticus as a cause of confusion in an elderly patient. J Formos Med Assoc. 2015;114:290\u20131.","journal-title":"J Formos Med Assoc."},{"key":"578_CR238","first-page":"119","volume":"63","author":"M-C Parotte","year":"2008","unstructured":"Parotte M-C, Krzesinski J-M. Clinical case of the month. Antibiotics and hemodialysis: three cases of neurotoxicity from Maxipime. Rev Med Liege. 2008;63:119\u201321.","journal-title":"Rev Med Liege"},{"key":"578_CR239","doi-asserted-by":"crossref","first-page":"388","DOI":"10.5414\/CNP59388","volume":"59","author":"N Ferrara","year":"2003","unstructured":"Ferrara N, Abete P, Giordano M, Ferrara P, Carnovale V, Leosco D, et al. Neurotoxicity induced by cefepime in a very old hemodialysis patient. Clin Nephrol. 2003;59:388\u201390.","journal-title":"Clin Nephrol."},{"key":"578_CR240","first-page":"273","volume":"33","author":"M Heras","year":"2013","unstructured":"Heras M, Parra MA, Mac\u00edas MC, Azanza JR, Prado F, S\u00e1nchez R, et al. Effectiveness of early haemodialysis in cefepime-induced neurotoxicity. Nefrologia. 2013;33:273\u20135.","journal-title":"Nefrologia."},{"key":"578_CR241","first-page":"312","volume":"14","author":"NL Smith","year":"2012","unstructured":"Smith NL, Freebairn RC, Park MAJ, Wallis SC, Roberts JA, Lipman J. Therapeutic drug monitoring when using cefepime in continuous renal replacement therapy: seizures associated with cefepime. Crit Care Resusc. 2012;14:312\u20135.","journal-title":"Crit Care Resusc."},{"key":"578_CR242","doi-asserted-by":"crossref","first-page":"54","DOI":"10.2146\/ajhp050512","volume":"64","author":"I Spriet","year":"2007","unstructured":"Spriet I, Meersseman W, De Troy E, Wilmer A, Casteels M, Willems L. Meropenem\u2013valproic acid interaction in patients with cefepime-associated status epilepticus. Am J Health Syst Pharm. 2007;64:54\u20138.","journal-title":"Am J Health Syst Pharm."},{"key":"578_CR243","first-page":"1026","volume":"22","author":"M Yadla","year":"2011","unstructured":"Yadla M, Kishore CK, Sriramnaveen P, Reddy YS, Sainaresh VV, Bhuma V, et al. Neurotoxicity due to cefepime in patients on maintenance hemodialysis. Saudi J Kidney Transpl. 2011;22:1026\u20137.","journal-title":"Saudi J Kidney Transpl."},{"key":"578_CR244","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1212\/WNL.0000000000001365","volume":"84","author":"S Khasani","year":"2015","unstructured":"Khasani S. Cefepime-induced jaw myoclonus. Neurology. 2015;84:1183.","journal-title":"Neurology."},{"key":"578_CR245","unstructured":"FDA Drug Safety Communication. Cefepime and risk of seizure in patients not receiving dosage adjustments for kidney impairment. 2012. http:\/\/www.fda.gov\/Drugs\/DrugSafety\/ucm309661.htm . Accessed 8 May 2016."},{"key":"578_CR246","doi-asserted-by":"crossref","first-page":"68S","DOI":"10.1016\/S0002-9343(96)00110-6","volume":"100","author":"HC Neu","year":"1996","unstructured":"Neu HC. Safety of cefepime: a new extended-spectrum parenteral cephalosporin. Am J Med. 1996;100:68S\u201375S.","journal-title":"Am J Med."},{"key":"578_CR247","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/0002-9343(88)90071-X","volume":"84","author":"G Calandra","year":"1988","unstructured":"Calandra G, Lydick E, Carrigan J, Weiss L, Guess H. Factors predisposing to seizures in seriously ill infected patients receiving antibiotics: experience with imipenem\/cilastatin. Am J Med. 1988;84:911\u20138.","journal-title":"Am J Med."},{"key":"578_CR248","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1093\/jac\/dku111","volume":"69","author":"JP Cannon","year":"2014","unstructured":"Cannon JP, Lee TA, Clark NM, Setlak P, Grim SA. The risk of seizures among the carbapenems: a meta-analysis. J Antimicrob Chemother. 2014;69:2043\u201355.","journal-title":"J Antimicrob Chemother."},{"key":"578_CR249","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1097\/INF.0b013e31828be70b","volume":"32","author":"CP Hornik","year":"2013","unstructured":"Hornik CP, Herring AH, Benjamin DK, Capparelli EV, Kearns GL, van den Anker J, et al. Adverse events associated with meropenem versus imipenem\/cilastatin therapy in a large retrospective cohort of hospitalized infants. Pediatr Infect Dis J. 2013;32:748\u201353.","journal-title":"Pediatr Infect Dis J."},{"key":"578_CR250","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1097\/00003246-199808000-00047","volume":"26","author":"J Schranz","year":"1998","unstructured":"Schranz J. Comparisons of seizure incidence and adverse experiences between imipenem and meropenem. Crit Care Med. 1998;26:1464\u20135.","journal-title":"Crit Care Med."},{"key":"578_CR251","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2165\/00002018-199615020-00001","volume":"15","author":"SR Norrby","year":"1996","unstructured":"Norrby SR. Neurotoxicity of carbapenem antibacterials. Drug Saf. 1996;15:87\u201390.","journal-title":"Drug Saf."},{"key":"578_CR252","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/00006454-199102000-00009","volume":"10","author":"VK Wong","year":"1991","unstructured":"Wong VK, Wright HT, Ross LA, Mason WH, Inderlied CB, Kim KS. Imipenem\/cilastatin treatment of bacterial meningitis in children. Pediatr Infect Dis J. 1991;10:122\u20135.","journal-title":"Pediatr Infect Dis J."},{"key":"578_CR253","doi-asserted-by":"crossref","first-page":"849","DOI":"10.7326\/0003-4819-115-11-849","volume":"115","author":"DJ Winston","year":"1991","unstructured":"Winston DJ, Ho WG, Bruckner DA, Champlin RE. Beta-lactam antibiotic therapy in febrile granulocytopenic patients. A randomized trial comparing cefoperazone plus piperacillin, ceftazidime plus piperacillin, and imipenem alone. Ann Intern Med. 1991;115:849\u201359.","journal-title":"Ann Intern Med."},{"key":"578_CR254","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1001\/archinte.1990.00390190181040","volume":"150","author":"RB Brown","year":"1990","unstructured":"Brown RB, Sands M, Morris AB. Seizure propensity with imipenem. Arch Intern Med. 1990;150:1551.","journal-title":"Arch Intern Med."},{"key":"578_CR255","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1177\/155005940403500210","volume":"35","author":"JL Fern\u00e1ndez-Torre","year":"2004","unstructured":"Fern\u00e1ndez-Torre JL, Velasco M, Fern\u00e1ndez-Sampedro M, Guti\u00e9rrez R. Encephalopathy secondary to imipenem therapy. Clin EEG Neurosci. 2004;35:100\u20133.","journal-title":"Clin EEG Neurosci."},{"key":"578_CR256","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1177\/106002809002400504","volume":"24","author":"ML Job","year":"1990","unstructured":"Job ML, Dretler RH. Seizure activity with imipenem therapy: incidence and risk factors. DICP. 1990;24:467\u20139.","journal-title":"DICP."},{"key":"578_CR257","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1177\/106002809102500403","volume":"25","author":"RJ Leo","year":"1991","unstructured":"Leo RJ, Ballow CH. Seizure activity associated with imipenem use: clinical case reports and review of the literature. DICP. 1991;25:351\u20134.","journal-title":"DICP."},{"key":"578_CR258","first-page":"221","volume":"75","author":"D Galante","year":"2009","unstructured":"Galante D. An unusual cause of seizures during subarachnoid anesthesia in a patient undergoing transurethral resection of the prostate: a case report. Minerva Anestesiol. 2009;75:221\u20133.","journal-title":"Minerva Anestesiol."},{"key":"578_CR259","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1001\/archinte.1989.00390080131029","volume":"149","author":"RH Eng","year":"1989","unstructured":"Eng RH, Munsif AN, Yangco BG, Smith SM, Chmel H. Seizure propensity with imipenem. Arch Intern Med. 1989;149:1881\u20133.","journal-title":"Arch Intern Med."},{"key":"578_CR260","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1159\/000186453","volume":"58","author":"C B\u00f6sm\u00fcller","year":"1991","unstructured":"B\u00f6sm\u00fcller C, Steurer W, K\u00f6nigsrainer A, Willeit J, Margreiter R. Increased risk of central nervous system toxicity in patients treated with ciclosporin and imipenem\/cilastatin. Nephron. 1991;58:362\u20134.","journal-title":"Nephron."},{"key":"578_CR261","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1093\/ajhp\/53.17.2097","volume":"53","author":"BJ Guglielmo","year":"1996","unstructured":"Guglielmo BJ, Jacobs RA. Impact of dosage-monitoring system on frequency of seizures associated with imipenem\u2013cilastatin. Am J Health Syst Pharm. 1996;53:2097\u20138.","journal-title":"Am J Health Syst Pharm."},{"key":"578_CR262","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1093\/ajhp\/53.13.1605","volume":"53","author":"M Lane","year":"1996","unstructured":"Lane M, Kania D, Rapp RP. Seizures related to use of imipenem\u2013cilastatin. Am J Health Syst Pharm. 1996;53:1605\u20136.","journal-title":"Am J Health Syst Pharm."},{"key":"578_CR263","first-page":"1133","volume":"49","author":"HW Newcomb","year":"1992","unstructured":"Newcomb HW, Hill EM, McCarthy ID, Mostow SR. Imipenem\u2013cilastatin dosing intervention program by pharmacists. Am J Hosp Pharm. 1992;49:1133\u20135.","journal-title":"Am J Hosp Pharm."},{"key":"578_CR264","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1177\/106002809102500402","volume":"25","author":"SR Abel","year":"1991","unstructured":"Abel SR, Guba EA. Evaluation of an imipenem\/cilastatin target drug program. DICP. 1991;25:348\u201350.","journal-title":"DICP."},{"key":"578_CR265","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/00007611-199104000-00013","volume":"84","author":"JD Semel","year":"1991","unstructured":"Semel JD, Allen N. Seizures in patients simultaneously receiving theophylline and imipenem or ciprofloxacin or metronidazole. South Med J. 1991;84:465\u20138.","journal-title":"South Med J."},{"key":"578_CR266","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0025-7753(00)71558-2","volume":"115","author":"J Grau Cat","year":"2000","unstructured":"Grau Cat J, Batlle M, Coll-Cant\u00ed J, Ribera JM. Left hemiasomatognosia probably induced by imipenem. Med Clin (Barc). 2000;115:358\u20139.","journal-title":"Med Clin (Barc)."},{"key":"578_CR267","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1093\/ndt\/13.7.1896","volume":"13","author":"M Campise","year":"1998","unstructured":"Campise M. Neurological complication during imipenem\/cilastatin therapy in uraemic patients. Nephrol Dial Transpl. 1998;13:1895\u20136.","journal-title":"Nephrol Dial Transpl."},{"key":"578_CR268","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1177\/106002809302700418","volume":"27","author":"SL Pestotnik","year":"1993","unstructured":"Pestotnik SL, Classen DC, Evans RS, Stevens LE, Burke JP. Prospective surveillance of imipenem\/cilastatin use and associated seizures using a hospital information system. Ann Pharmacother. 1993;27:497\u2013501.","journal-title":"Ann Pharmacother."},{"key":"578_CR269","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.ijantimicag.2009.06.001","volume":"34","author":"F Lamoth","year":"2009","unstructured":"Lamoth F, Erard V, Asner S, Buclin T, Calandra T, Marchetti O. High imipenem blood concentrations associated with toxic encephalopathy in a patient with mild renal dysfunction. Int J Antimicrob Agents. 2009;34:386\u20138.","journal-title":"Int J Antimicrob Agents."},{"key":"578_CR270","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1590\/S0004-282X2010000100030","volume":"68","author":"A Finkelsztejn","year":"2010","unstructured":"Finkelsztejn A, Cabral L, Bragatti JA, da Silva AV, Schuh AFS. Imipenem-associated encephalopathy: alert to physicians. Arq Neuropsiquiatr. 2010;68:137\u20139.","journal-title":"Arq Neuropsiquiatr."},{"key":"578_CR271","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1007\/s00467-004-1467-3","volume":"19","author":"KK Lau","year":"2004","unstructured":"Lau KK, Kink RJ, Jones DP. Myoclonus associated with intraperitoneal imipenem. Pediatr Nephrol. 2004;19:700\u20131.","journal-title":"Pediatr Nephrol."},{"key":"578_CR272","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/mds.870120430","volume":"12","author":"S Frucht","year":"1997","unstructured":"Frucht S, Eidelberg D. Imipenem-induced myoclonus. Mov Disord. 1997;12:621\u20132.","journal-title":"Mov Disord."},{"key":"578_CR273","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/ndt\/14.1.258","volume":"14","author":"M Rivera","year":"1999","unstructured":"Rivera M, Crespo M, Teruel JL, Marc\u00e9n R, Ortu\u00f1o J. Neurotoxicity due to imipenem\/cilastatin in patients on continuous ambulatory peritoneal dialysis. Nephrol Dial Transpl. 1999;14:258\u20139.","journal-title":"Nephrol Dial Transpl."},{"key":"578_CR274","first-page":"1323","volume":"23","author":"JJ Ortega","year":"1995","unstructured":"Ortega JJ, Geffner D, Salas R, Serrano AL. Myoclonic jerks secondary to imipemen. Rev Neurol. 1995;23:1323.","journal-title":"Rev Neurol."},{"key":"578_CR275","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1177\/106002809102500920","volume":"25","author":"A Duque","year":"1991","unstructured":"Duque A, Altimiras J, Garc\u00eda-Cases C, Vidal P. Vertigo caused by intravenous imipenem\/cilastatin. DICP. 1991;25:1009.","journal-title":"DICP."},{"key":"578_CR276","doi-asserted-by":"crossref","first-page":"657","DOI":"10.2165\/00002018-200730080-00002","volume":"30","author":"P Linden","year":"2007","unstructured":"Linden P. Safety profile of meropenem: an updated review of over 6,000 patients treated with meropenem. Drug Saf. 2007;30:657\u201368.","journal-title":"Drug Saf."},{"key":"578_CR277","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ijantimicag.2007.09.011","volume":"31","author":"IG Baraboutis","year":"2008","unstructured":"Baraboutis IG, Marangos MN, Skoutelis A, Bassaris H. Meropenem-aggravated seizure activity in progressive myoclonus epilepsy. Int J Antimicrob Agents. 2008;31:177\u20139.","journal-title":"Int J Antimicrob Agents."},{"key":"578_CR278","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0924-8579(98)00031-4","volume":"10","author":"BA Cunha","year":"1998","unstructured":"Cunha BA. Meropenem in elderly and renally impaired patients. Int J Antimicrob Agents. 1998;10:107\u201317.","journal-title":"Int J Antimicrob Agents."},{"key":"578_CR279","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1179\/1973947814Y.0000000179","volume":"27","author":"S Munoz-Gomez","year":"2015","unstructured":"Munoz-Gomez S, Gran A, Cunha BA. Meropenem delirium: a previously unrecognized neurologic side effect. J Chemother. 2015;27:120\u20131.","journal-title":"J Chemother."},{"key":"578_CR280","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.seizure.2014.06.017","volume":"23","author":"T Spina Silva","year":"2014","unstructured":"Spina Silva T, Dal-Pr\u00e1 Ducci R, Zorzetto FP, Braatz VL, de Paola L, Kowacs PA. Meropenem-induced myoclonus: a case report. Seizure. 2014;23:912\u20134.","journal-title":"Seizure."},{"key":"578_CR281","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1086\/505304","volume":"43","author":"L Saidel-Odes","year":"2006","unstructured":"Saidel-Odes L, Borer A, Riesenberg K, Smolyakov R, Schlaeffer F. History of cerebrovascular events: a relative contraindication to ertapenem treatment. Clin Infect Dis. 2006;43:262\u20133.","journal-title":"Clin Infect Dis."},{"key":"578_CR282","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1080\/00365540802375570","volume":"40","author":"AE Fica","year":"2008","unstructured":"Fica AE, Abusada NJ. Seizures associated with ertapenem use in patients with CNS disorders and renal insufficiency. Scand J Infect Dis. 2008;40:983\u20135.","journal-title":"Scand J Infect Dis."},{"key":"578_CR283","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.ijantimicag.2007.08.024","volume":"31","author":"C Ong","year":"2008","unstructured":"Ong C, Chua AC, Tambyah PA, Fei YS. Seizures associated with ertapenem. Int J Antimicrob Agents. 2008;31:290.","journal-title":"Int J Antimicrob Agents."},{"key":"578_CR284","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/jcpt.12239","volume":"40","author":"K-H Lee","year":"2015","unstructured":"Lee K-H, Ueng Y-F, Wu C-W, Chou Y-C, Ng Y-Y, Yang W-C. The recommended dose of ertapenem poses a potential risk for central nervous system toxicity in haemodialysis patients\u2014case reports and literature reviews. J Clin Pharm Ther. 2015;40:240\u20134.","journal-title":"J Clin Pharm Ther."},{"key":"578_CR285","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1345\/aph.1E421","volume":"39","author":"AH Seto","year":"2005","unstructured":"Seto AH. Ertapenem-associated seizures in a peritoneal dialysis patient. Ann Pharmacother. 2005;39:352\u20136.","journal-title":"Ann Pharmacother."},{"key":"578_CR286","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/1744-9987.12334","volume":"20","author":"F Y\u0131lmaz","year":"2016","unstructured":"Y\u0131lmaz F, Uslu H, Ersoy F. Ertapenem associated with seizures in treatment of pyelonephritis in a chronic peritoneal dialysis patient. Ther Apher Dial. 2016;20:89\u201390.","journal-title":"Ther Apher Dial."},{"key":"578_CR287","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.nrl.2014.02.008","volume":"30","author":"R Padilla Peinado","year":"2015","unstructured":"Padilla Peinado R, Esteban Fern\u00e1ndez J, Rodr\u00edguez \u00c1lvarez S, Villa Albuguer T. Visual hallucinations related to use of ertapenem. Neurologia. 2015;30:520\u20131.","journal-title":"Neurologia."},{"key":"578_CR288","doi-asserted-by":"crossref","first-page":"255","DOI":"10.5414\/CP202043","volume":"52","author":"N So\u0161taric","year":"2014","unstructured":"So\u0161taric N, Beovic B, Maticic M. Ertapenem-associated seizures in a patient without prior CNS disorder or severe renal dysfunction. Int J Clin Pharmacol Ther. 2014;52:255\u20138.","journal-title":"Int J Clin Pharmacol Ther."},{"key":"578_CR289","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1086\/339543","volume":"34","author":"G Ortiz-Ruiz","year":"2002","unstructured":"Ortiz-Ruiz G, Caballero-Lopez J, Friedland IR, Woods GL, Carides A, Group P 018 EC-APS, et al. A study evaluating the efficacy, safety, and tolerability of ertapenem versus ceftriaxone for the treatment of community-acquired pneumonia in adults. Clin Infect Dis. 2002;34:1076\u201383.","journal-title":"Clin Infect Dis."},{"key":"578_CR290","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1345\/aph.1P528","volume":"45","author":"S Duquaine","year":"2011","unstructured":"Duquaine S, Kitchell E, Tate T, Tannen RC, Wickremasinghe IM. Central nervous system toxicity associated with ertapenem use. Ann Pharmacother. 2011;45:e6.","journal-title":"Ann Pharmacother."},{"key":"578_CR291","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1111\/imj.12504","volume":"44","author":"Y Oo","year":"2014","unstructured":"Oo Y, Packham D, Yau W, Munckhof WJ. Ertapenem-associated psychosis and encephalopathy. Intern Med J. 2014;44:817\u20139.","journal-title":"Intern Med J."},{"key":"578_CR292","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.psym.2015.02.002","volume":"56","author":"K Apodaca","year":"2015","unstructured":"Apodaca K, Baker J, Bin-Bilal H, Raskin Y, Quinn DK. Ertapenem-induced delirium: a case report and literature review. Psychosomatics. 2015;56:561\u20136.","journal-title":"Psychosomatics."},{"key":"578_CR293","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s11096-013-9812-x","volume":"35","author":"Y Shea","year":"2013","unstructured":"Shea Y, Mok MM, Cheng K, Hon FS, Chu L. Delayed recovery from ertapenem induced encephalopathy: case-report and a possible mechanism. Int J Clin Pharm. 2013;35:535\u20137.","journal-title":"Int J Clin Pharm."},{"key":"578_CR294","first-page":"76","volume":"122","author":"V Kong","year":"2009","unstructured":"Kong V, Beckert L, Awunor-Renner C. A case of beta lactam-induced visual hallucination. N Z Med J.\u00a02009;122:76\u20137.","journal-title":"N Z Med J"},{"key":"578_CR295","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1097\/CCM.0b013e3181691b99","volume":"36","author":"J Chastre","year":"2008","unstructured":"Chastre J, Wunderink R, Prokocimer P, Lee M, Kaniga K, Friedland I. Efficacy and safety of intravenous infusion of doripenem versus imipenem in ventilator-associated pneumonia: a multicenter, randomized study. Crit Care Med. 2008;36:1089\u201396.","journal-title":"Crit Care Med."},{"key":"578_CR296","doi-asserted-by":"crossref","first-page":"709","DOI":"10.2165\/00002018-200932090-00001","volume":"32","author":"GG Zhanel","year":"2009","unstructured":"Zhanel GG, Ketter N, Rubinstein E, Friedland I, Redman R. Overview of seizure-inducing potential of doripenem. Drug Saf. 2009;32:709\u201316.","journal-title":"Drug Saf."},{"key":"578_CR297","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1185\/03007990802179255","volume":"24","author":"A R\u00e9a-Neto","year":"2008","unstructured":"R\u00e9a-Neto A, Niederman M, Lobo SM, Schroeder E, Lee M, Kaniga K, et al. Efficacy and safety of doripenem versus piperacillin\/tazobactam in nosocomial pneumonia: a randomized, open-label, multicenter study. Curr Med Res Opin. 2008;24:2113\u201326.","journal-title":"Curr Med Res Opin."},{"key":"578_CR298","doi-asserted-by":"crossref","first-page":"651","DOI":"10.11150\/kansenshogakuzasshi1970.72.651","volume":"72","author":"K Katsuki","year":"1998","unstructured":"Katsuki K, Shinohara K, Yamada T. A case of fatal seizure and unconsciousness caused by panipenem\/betamipron. Kansenshogaku Zasshi. 1998;72:651\u20133.","journal-title":"Kansenshogaku Zasshi."},{"key":"578_CR299","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1515\/DMDI.2009.24.2-4.153","volume":"24","author":"JK Tobin","year":"2009","unstructured":"Tobin JK, Golightly LK, Kick SD, Jones MA. Valproic acid\u2013carbapenem interaction: report of six cases and a review of the literature. Drug Metabol Drug Interact. 2009;24:153\u201382.","journal-title":"Drug Metabol Drug Interact."},{"key":"578_CR300","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1002\/jps.20338","volume":"94","author":"K Omoda","year":"2005","unstructured":"Omoda K, Murakami T, Yumoto R, Nagai J, Maeda Y, Kiribayashi Y, et al. Increased erythrocyte distribution of valproic acid in pharmacokinetic interaction with carbapenem antibiotics in rat and human. J Pharm Sci. 2005;94:1685\u201393.","journal-title":"J Pharm Sci."},{"key":"578_CR301","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/FTD.0b013e318260f7b3","volume":"34","author":"MK Park","year":"2012","unstructured":"Park MK, Lim KS, Kim T-E, Han H-K, Yi S-J, Shin K-H, et al. Reduced valproic acid serum concentrations due to drug interactions with carbapenem antibiotics: overview of 6 cases. Ther Drug Monit. 2012;34:599\u2013603.","journal-title":"Ther Drug Monit."},{"key":"578_CR302","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ejpn.2014.12.010","volume":"19","author":"MC Miranda Herrero","year":"2015","unstructured":"Miranda Herrero MC, Alcaraz Romero AJ, Escudero Vilaplana V, Fern\u00e1ndez Lafever SN, Fern\u00e1ndez-Llamazares CM, Barredo Valderrama E, et al. Pharmacological interaction between valproic acid and carbapenem: what about levels in pediatrics? Eur J Paediatr Neurol. 2015;19:155\u201361.","journal-title":"Eur J Paediatr Neurol."},{"key":"578_CR303","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.medcli.2008.06.018","volume":"132","author":"AM Borobia","year":"2009","unstructured":"Borobia AM, Fudio S, Carcas Sansu\u00e1n AJ. Valproate\u2013meropenem co-administration, an example of information shortcomings in relevant drug interactions. Med Clin (Barc). 2009;132:803\u20134.","journal-title":"Med Clin (Barc)."},{"key":"578_CR304","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1345\/aph.1K079","volume":"41","author":"I Spriet","year":"2007","unstructured":"Spriet I, Goyens J, Meersseman W, Wilmer A, Willems L, Paesschen WV. Interaction between valproate and meropenem: a retrospective study. Ann Pharmacother. 2007;41:1130\u20136.","journal-title":"Ann Pharmacother."},{"key":"578_CR305","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1177\/0091270009334377","volume":"49","author":"S Haroutiunian","year":"2009","unstructured":"Haroutiunian S, Ratz Y, Rabinovich B, Adam M, Hoffman A. Valproic acid plasma concentration decreases in a dose-independent manner following administration of meropenem: a retrospective study. J Clin Pharmacol. 2009;49:1363\u20139.","journal-title":"J Clin Pharmacol."},{"key":"578_CR306","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1345\/aph.1M296","volume":"43","author":"EE Mancl","year":"2009","unstructured":"Mancl EE, Gidal BE. The effect of carbapenem antibiotics on plasma concentrations of valproic acid. Ann Pharmacother. 2009;43:2082\u20137.","journal-title":"Ann Pharmacother."},{"key":"578_CR307","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1080\/03602530701690341","volume":"39","author":"H Mori","year":"2007","unstructured":"Mori H, Takahashi K, Mizutani T. Interaction between valproic acid and carbapenem antibiotics. Drug Metab Rev. 2007;39:647\u201357.","journal-title":"Drug Metab Rev."},{"key":"578_CR308","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1124\/dmd.104.000661","volume":"32","author":"Y Nakajima","year":"2004","unstructured":"Nakajima Y, Mizobuchi M, Nakamura M, Takagi H, Inagaki H, Kominami G, et al. Mechanism of the drug interaction between valproic acid and carbapenem antibiotics in monkeys and rats. Drug Metab Dispos. 2004;32:1383\u201391.","journal-title":"Drug Metab Dispos."},{"key":"578_CR309","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.pediatrneurol.2013.03.022","volume":"49","author":"FA Taha","year":"2013","unstructured":"Taha FA, Hammond DN, Sheth RD. Seizures from valproate\u2013carbapenem interaction. Pediatr Neurol. 2013;49:279\u201381.","journal-title":"Pediatr Neurol."},{"key":"578_CR310","doi-asserted-by":"crossref","first-page":"400","DOI":"10.4067\/S0034-98872014000300019","volume":"142","author":"D Berardi","year":"2014","unstructured":"Berardi D, Clemente R, Finn BC, Bruetman JE, Young P. Not to forget interaction between meropenem and valproic acid. Rev Med Chil. 2014;142:400\u20131.","journal-title":"Rev Med Chil"},{"key":"578_CR311","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1007\/s00134-005-2695-0","volume":"31","author":"D Clause","year":"2005","unstructured":"Clause D, Decleire P-Y, Vanbinst R, Soyer A, Hantson P. Pharmacokinetic interaction between valproic acid and meropenem. Intensive Care Med. 2005;31:1293\u20134.","journal-title":"Intensive Care Med."},{"key":"578_CR312","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1365-2710.2006.00743.x","volume":"31","author":"S Fudio","year":"2006","unstructured":"Fudio S, Carcas A, Pinana E, Ortega R. Epileptic seizures caused by low valproic acid levels from an interaction with meropenem. J Clin Pharm Ther. 2006;31:393\u20136.","journal-title":"J Clin Pharm Ther."},{"key":"578_CR313","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1177\/08830738050200051401","volume":"20","author":"M Santucci","year":"2005","unstructured":"Santucci M, Parmeggiani A, Riva R. Seizure worsening caused by decreased serum valproate during meropenem therapy. J Child Neurol. 2005;20:456\u20137.","journal-title":"J Child Neurol."},{"key":"578_CR314","first-page":"258","volume":"27","author":"F Llinares Tello","year":"2003","unstructured":"Llinares Tello F, Bosacoma Ros N, Hern\u00e1ndez Prats C, Climent Grana E, Selva Otaolaurruchi J, Ordov\u00e1s Baines JP. Pharmacokinetic interaction between valproic acid and carbapenem-like antibiotics: a discussion of three cases. Farm Hosp. 2003;27:258\u201363.","journal-title":"Farm Hosp"},{"key":"578_CR315","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1345\/aph.1E358","volume":"39","author":"FJ Coves-Orts","year":"2005","unstructured":"Coves-Orts FJ. Acute seizures due to a probable interaction between valproic acid and meropenem. Ann Pharmacother. 2005;39:533\u20137.","journal-title":"Ann Pharmacother."},{"key":"578_CR316","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.amjopharm.2009.02.005","volume":"7","author":"J Gu","year":"2009","unstructured":"Gu J, Huang Y. Effect of concomitant administration of meropenem and valproic acid in an elderly Chinese patient. Am J Geriatr Pharmacother. 2009;7:26\u201333.","journal-title":"Am J Geriatr Pharmacother."},{"key":"578_CR317","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.pediatrneurol.2004.03.014","volume":"31","author":"E Nacarkucuk","year":"2004","unstructured":"Nacarkucuk E, Saglam H, Okan M. Meropenem decreases serum level of valproic acid. Pediatr Neurol. 2004;31:232\u20134.","journal-title":"Pediatr Neurol."},{"key":"578_CR318","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0025-7753(04)74403-6","volume":"123","author":"A P\u00e9rez Plasencia","year":"2004","unstructured":"P\u00e9rez Plasencia A, Soy D, Nicolas JM. Pharmacokinetic interaction between valproic acid and meropenem. Med Clin (Barc). 2004;123:38\u20139.","journal-title":"Med Clin (Barc)."},{"key":"578_CR319","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.medcli.2010.06.026","volume":"137","author":"MI Fern\u00e1ndez Garc\u00eda","year":"2011","unstructured":"Fern\u00e1ndez Garc\u00eda MI, de la Puebla Fern\u00e1ndez, Gim\u00e9nez R\u00c1, Garc\u00eda Olid B, Torres Degay\u00f3n V. Meropenem decreases valproate plasmatic concentrations. Med Clin (Barc). 2011;137:43\u20134.","journal-title":"Med Clin (Barc)."},{"key":"578_CR320","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.nrl.2011.03.008","volume":"27","author":"MV D\u00edaz-Pallar\u00e9s","year":"2012","unstructured":"D\u00edaz-Pallar\u00e9s MV, Silveira ED, D\u00edaz A\u00c1, Men\u00e9ndez-Conde CP, Oliveros NV, Vicedo TB. An\u00e1lisis de la interacci\u00f3n \u00e1cido valproico\u2013meropenem en pacientes hospitalizados. Neurologia. 2012;27:34\u20138.","journal-title":"Neurologia."},{"key":"578_CR321","doi-asserted-by":"crossref","first-page":"353","DOI":"10.4067\/S0716-10182012000300018","volume":"29","author":"C Gonz\u00e1lez","year":"2012","unstructured":"Gonz\u00e1lez C, Villena R. Pharmacological interaction between meropenem and valproic acid: a report of two cases. Rev Chil Infectol. 2012;29:353\u20135.","journal-title":"Rev Chil Infectol"},{"key":"578_CR322","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S1695-4033(06)70016-9","volume":"64","author":"F Sala Pi\u00f1ol","year":"2006","unstructured":"Sala Pi\u00f1ol F, Padull\u00e9s Zamora N, Hidalgo Albert E, Clemente Bautista S, Caba\u00f1as Poy MJ, Oliveras Arenas M, et al. Pharmacokinetic interaction between valproic acid and meropenem. An Pediatr (Barc). 2006;64:93\u20135.","journal-title":"An Pediatr (Barc)."},{"key":"578_CR323","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/jac\/42.4.563","volume":"42","author":"BJ Turck De","year":"1998","unstructured":"De Turck BJ, Diltoer MW, Cornelis PJ, Maes V, Spapen HD, Camu F, et al. Lowering of plasma valproic acid concentrations during concomitant therapy with meropenem and amikacin. J Antimicrob Chemother. 1998;42:563\u20134.","journal-title":"J Antimicrob Chemother."},{"key":"578_CR324","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.anpedi.2008.08.009","volume":"70","author":"V San Antonio Arce","year":"2009","unstructured":"San Antonio Arce V, Joyanes Abancens B. Meropenem and valproic acid. An interaction to remember. An Pediatr (Barc). 2009;70:193\u20134.","journal-title":"An Pediatr (Barc)."},{"key":"578_CR325","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.medcli.2009.06.063","volume":"135","author":"C Ib\u00e1\u00f1ez Ruiz","year":"2010","unstructured":"Ib\u00e1\u00f1ez Ruiz C, Esteban Calvo C, L\u00f3pez-Oliva AG, Cach\u00e1 Acosta A. Valproate\u2013meropenem interaction as an example of information shortcomings in relevant drug interactions. Med Clin (Barc). 2010;135:623\u20134.","journal-title":"Med Clin (Barc)."},{"key":"578_CR326","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.2146\/ajhp090069","volume":"67","author":"F-F Liao","year":"2010","unstructured":"Liao F-F, Huang Y-B, Chen C-Y. Decrease in serum valproic acid levels during treatment with ertapenem. Am J Health Syst Pharm. 2010;67:1260\u20134.","journal-title":"Am J Health Syst Pharm."},{"key":"578_CR327","doi-asserted-by":"crossref","first-page":"315","DOI":"10.4212\/cjhp.v63i4.936","volume":"63","author":"D Bates","year":"2010","unstructured":"Bates D, Parkins M, Duggan K. Ertapenem-induced reduction in valproate levels: case report and review of the literature. Can J Hosp Pharm. 2010;63:315\u201322.","journal-title":"Can J Hosp Pharm."},{"key":"578_CR328","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S1130-6343(06)73997-6","volume":"30","author":"MA Cabanes Mariscal","year":"2006","unstructured":"Cabanes Mariscal MA, S\u00e1nchez L\u00f3pez P, Alvarez Herranz P, Chamorro Merino G. Pharmacokinetic interaction between valproic acid and ertapenem. Farm Hosp. 2006;30:313\u20135.","journal-title":"Farm Hosp."},{"key":"578_CR329","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1592\/phco.27.8.1202","volume":"27","author":"JL Lunde","year":"2007","unstructured":"Lunde JL, Nelson RE, Storandt HF. Acute seizures in a patient receiving divalproex sodium after starting ertapenem therapy. Pharmacotherapy. 2007;27:1202\u20135.","journal-title":"Pharmacotherapy."},{"key":"578_CR330","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1007\/s11096-013-9763-2","volume":"35","author":"H Yoon","year":"2013","unstructured":"Yoon H, Kim DH. Unusual drug reaction between valproate sodium and meropenem. Int J Clin Pharm. 2013;35:316\u20138.","journal-title":"Int J Clin Pharm."},{"key":"578_CR331","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S1130-6343(06)73999-X","volume":"30","author":"M Perea Falomir","year":"2006","unstructured":"Perea Falomir M, Roura Poch P, Higueruelo Demas\u00f3n S, Garc\u00eda Gil VJ. Pharmacokinetic interaction between valproic acid and imipenem. Farm Hosp. 2006;30:316\u20137.","journal-title":"Farm Hosp"},{"key":"578_CR332","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/jac\/39.2.295","volume":"39","author":"K Nagai","year":"1997","unstructured":"Nagai K, Shimizu T, Togo A, Takeya M, Yokomizo Y, Sakata Y, et al. Decrease in serum levels of valproic acid during treatment with a new carbapenem, panipenem\/betamipron. J Antimicrob Chemother. 1997;39:295\u20136.","journal-title":"J Antimicrob Chemother."},{"key":"578_CR333","doi-asserted-by":"crossref","first-page":"92","DOI":"10.5414\/CP202188","volume":"53","author":"A Shihyakugari","year":"2015","unstructured":"Shihyakugari A, Miki A, Nakamoto N, Satoh H, Sawada Y. First case report of suspected onset of convulsive seizures due to co-administration of valproic acid and tebipenem. Int J Clin Pharmacol Ther. 2015;53:92\u20136.","journal-title":"Int J Clin Pharmacol Ther."},{"key":"578_CR334","doi-asserted-by":"crossref","first-page":"54","DOI":"10.2174\/157488611794480007","volume":"6","author":"TR Hellwig","year":"2011","unstructured":"Hellwig TR, Onisk ML, Chapman BA. Potential interaction between valproic acid and doripenem. Curr Drug Saf. 2011;6:54\u20138.","journal-title":"Curr Drug Saf."},{"key":"578_CR335","unstructured":"Squibb B-M, Sons LLC. Azactam\u00ae (aztreonam for injection, USP). http:\/\/dailymed.nlm.nih.gov\/dailymed\/fda\/fdaDrugXsl.cfm?setid=9a105eaf-ee77-4016-beeb-d425a5565db2&type=display . Accessed 17 Apr 2016."},{"key":"578_CR336","doi-asserted-by":"crossref","first-page":"S120-123-132","DOI":"10.1097\/00006454-198909001-00007","volume":"8","author":"SA Chartrand","year":"1989","unstructured":"Chartrand SA. Safety and toxicity profile of aztreonam. Pediatr Infect Dis J. 1989;8:S120-123-132.","journal-title":"Pediatr Infect Dis J."},{"key":"578_CR337","doi-asserted-by":"crossref","first-page":"S648","DOI":"10.1093\/clinids\/7.Supplement_4.S648","volume":"7","author":"TJ Newman","year":"1985","unstructured":"Newman TJ, Dreslinski GR, Tadros SS. Safety profile of aztreonam in clinical trials. Rev Infect Dis. 1985;7:S648\u201355.","journal-title":"Rev Infect Dis."},{"key":"578_CR338","doi-asserted-by":"crossref","first-page":"S810","DOI":"10.1093\/clinids\/7.Supplement_4.S810","volume":"7","author":"K Hara","year":"1985","unstructured":"Hara K, Kobayashi H, Nishiura T, Yura J, Saito A. Clinical studies of aztreonam in Japan. Rev Infect Dis. 1985;7:S810\u201324.","journal-title":"Rev Infect Dis."},{"key":"578_CR339","doi-asserted-by":"crossref","first-page":"S831","DOI":"10.1093\/clinids\/7.Supplement_4.S831","volume":"7","author":"GK Daikos","year":"1985","unstructured":"Daikos GK. Clinical experience with aztreonam in four Mediterranean countries. Rev Infect Dis. 1985;7:S831\u20135.","journal-title":"Rev Infect Dis."},{"key":"578_CR340","doi-asserted-by":"crossref","first-page":"S825","DOI":"10.1093\/clinids\/7.Supplement_4.S825","volume":"7","author":"W Stille","year":"1985","unstructured":"Stille W, Gillissen J. Clinical experience with aztreonam in Germany and Austria. Rev Infect Dis. 1985;7:S825\u201330.","journal-title":"Rev Infect Dis."},{"key":"578_CR341","doi-asserted-by":"crossref","first-page":"S836","DOI":"10.1093\/clinids\/7.Supplement_4.S836","volume":"7","author":"SR Norrby","year":"1985","unstructured":"Norrby SR. Clinical experience with aztreonam in Europe: a summary of studies in Belgium, England, Finland, Ireland, the Netherlands, Norway, Portugal, and Sweden. Rev Infect Dis. 1985;7:S836\u20139.","journal-title":"Rev Infect Dis."},{"issue":"Suppl 1","key":"578_CR342","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1159\/000238719","volume":"35","author":"PA Ayroza-Galv\u00e3o","year":"1989","unstructured":"Ayroza-Galv\u00e3o PA, Milstein-Kuschnaroff TM, Mimica IM, Maassen S, Barbosa J\u00fanior SP, Cavalcante NJ, et al. Aztreonam in the treatment of bacterial meningitis. Chemotherapy. 1989;35(Suppl 1):39\u201344.","journal-title":"Chemotherapy."},{"key":"578_CR343","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/jac\/38.3.475","volume":"38","author":"A Sarro De","year":"1996","unstructured":"De Sarro A, Naccari F, Imperatore C, De Sarro GB. Comparative epileptogenic properties of two monobactam derivatives in C57, Swiss and DBA\/2 mice. J Antimicrob Chemother. 1996;38:475\u201384.","journal-title":"J Antimicrob Chemother."},{"key":"578_CR344","first-page":"129","volume":"42","author":"A Coquerel","year":"1985","unstructured":"Coquerel A, Mallet E, Senant J, Leroy A, Maitrot B. Factors of meningeal diffusion of amoxicillin and ampicillin at the acute phase of purulent meningitis in children. Arch Fr Pediatr. 1985;42:129\u201332.","journal-title":"Arch Fr Pediatr"},{"key":"578_CR345","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/0028-3908(85)90066-8","volume":"24","author":"B Esplin","year":"1985","unstructured":"Esplin B, Th\u00e9or\u00eat Y, Seward E, Capek R. Epileptogenic action of penicillin derivatives: structure\u2013activity relationship. Neuropharmacology. 1985;24:571\u20135.","journal-title":"Neuropharmacology."},{"key":"578_CR346","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0006-8993(76)91015-5","volume":"114","author":"MJ Gutnick","year":"1976","unstructured":"Gutnick MJ, Van Duijn H, Citri N. Relative convulsant potencies of structural analogues of penicillin. Brain Res. 1976;114:139\u201343.","journal-title":"Brain Res."},{"key":"578_CR347","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1128\/AAC.39.1.232","volume":"39","author":"A Sarro De","year":"1995","unstructured":"De Sarro A, Ammendola D, Zappala M, Grasso S, De Sarro GB. Relationship between structure and convulsant properties of some beta-lactam antibiotics following intracerebroventricular microinjection in rats. Antimicrob Agents Chemother. 1995;39:232\u20137.","journal-title":"Antimicrob Agents Chemother."},{"key":"578_CR348","doi-asserted-by":"crossref","first-page":"408","DOI":"10.7164\/antibiotics.48.408","volume":"48","author":"M Sunagawa","year":"1995","unstructured":"Sunagawa M, Matsumura H, Sumita Y, Nouda H. Structural features resulting in convulsive activity of carbapenem compounds: effect of C-2 side chain. J Antibiot (Tokyo). 1995;48:408\u201316.","journal-title":"J Antibiot (Tokyo)."},{"key":"578_CR349","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.tox.2006.02.004","volume":"222","author":"M Horiuchi","year":"2006","unstructured":"Horiuchi M, Kimura M, Tokumura M, Hasebe N, Arai T, Abe K. Absence of convulsive liability of doripenem, a new carbapenem antibiotic, in comparison with beta-lactam antibiotics. Toxicology. 2006;222:114\u201324.","journal-title":"Toxicology."},{"key":"578_CR350","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/0028-3908(89)90030-0","volume":"28","author":"A Sarro De","year":"1989","unstructured":"De Sarro A, De Sarro GB, Ascioti C, Nistic\u00f3 G. Epileptogenic activity of some beta-lactam derivatives: structure\u2013activity relationship. Neuropharmacology. 1989;28:359\u201365.","journal-title":"Neuropharmacology."},{"key":"578_CR351","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00702-011-0662-1","volume":"119","author":"M Gasior","year":"2012","unstructured":"Gasior M, Soca\u0142a K, Nieoczym D, Wla\u017a P. Clavulanic acid does not affect convulsions in acute seizure tests in mice. J Neural Transm (Vienna). 2012;119:1\u20136.","journal-title":"J Neural Transm (Vienna)."},{"key":"578_CR352","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.pbb.2009.04.013","volume":"93","author":"DJ Kim","year":"2009","unstructured":"Kim DJ, King JA, Zuccarelli L, Ferris CF, Koppel GA, Snowdon CT, et al. Clavulanic acid: a competitive inhibitor of beta-lactamases with novel anxiolytic-like activity and minimal side effects. Pharmacol Biochem Behav. 2009;93:112\u201320.","journal-title":"Pharmacol Biochem Behav."},{"key":"578_CR353","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nature03180","volume":"433","author":"JD Rothstein","year":"2005","unstructured":"Rothstein JD, Patel S, Regan MR, Haenggeli C, Huang YH, Bergles DE, et al. Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression. Nature. 2005;433:73\u20137.","journal-title":"Nature."},{"key":"578_CR354","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S1474-4422(14)70222-4","volume":"13","author":"ME Cudkowicz","year":"2014","unstructured":"Cudkowicz ME, Titus S, Kearney M, Yu H, Sherman A, Schoenfeld D, et al. Safety and efficacy of ceftriaxone for amyotrophic lateral sclerosis: a multi-stage, randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2014;13:1083\u201391.","journal-title":"Lancet Neurol."},{"key":"578_CR355","doi-asserted-by":"crossref","first-page":"4849","DOI":"10.1016\/j.bmcl.2008.07.085","volume":"18","author":"A Toda","year":"2008","unstructured":"Toda A, Ohki H, Yamanaka T, Murano K, Okuda S, Kawabata K, et al. Synthesis and SAR of novel parenteral anti-pseudomonal cephalosporins: discovery of FR264205. Bioorg Med Chem Lett. 2008;18:4849\u201352.","journal-title":"Bioorg Med Chem Lett."}],"container-title":["Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40264-017-0578-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-017-0578-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-017-0578-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T18:39:49Z","timestamp":1750790389000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40264-017-0578-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,28]]},"references-count":355,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["578"],"URL":"https:\/\/doi.org\/10.1007\/s40264-017-0578-2","relation":{},"ISSN":["0114-5916","1179-1942"],"issn-type":[{"value":"0114-5916","type":"print"},{"value":"1179-1942","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,28]]}}}